[10-Q] LSB INDUSTRIES INC Quarterly Earnings Report
Medtronic plc (MDT) – Form 4 insider filing. On 07/28/2025 the company granted equity awards to Harry Skip Kiil, EVP & President Cardiovascular. The filing shows no open-market trades; all transactions carry code “A” (award).
- Restricted Stock Units: 7,612 ordinary shares, vest 100% on the third anniversary. Beneficial ownership of ordinary shares rises to 41,318.
- Performance Share Units (PSUs): Target 19,028 shares (0–38,056 range) contingent on 3-year performance metrics concluding 04/28/2028.
- Stock Options: 53,671 options with a $91.97 strike, expiring 07/28/2035; 25% become exercisable each year starting 07/28/2026.
After the grants the insider directly holds 41,318 ordinary shares plus 19,028 PSUs and 53,671 options. The awards represent standard annual long-term incentive compensation meant to align management with shareholders and encourage retention. Given MDT’s ~1.3 bn share count, the dilution impact is immaterial (<0.01%). No sales were reported, so trading sentiment cannot be inferred.
Medtronic plc (MDT) – Comunicazione interna Form 4. Il 28/07/2025 la società ha assegnato premi azionari a Harry Skip Kiil, EVP e Presidente Cardiovascolare. La comunicazione non riporta operazioni sul mercato aperto; tutte le transazioni sono contrassegnate dal codice “A” (assegnazione).
- Restricted Stock Units: 7.612 azioni ordinarie, con maturazione del 100% al terzo anniversario. La proprietà effettiva delle azioni ordinarie sale a 41.318.
- Performance Share Units (PSU): Obiettivo di 19.028 azioni (intervallo 0–38.056) subordinato a metriche di performance triennali con scadenza il 28/04/2028.
- Stock Options: 53.671 opzioni con prezzo di esercizio di 91,97$, in scadenza il 28/07/2035; il 25% diventa esercitabile ogni anno a partire dal 28/07/2026.
Dopo queste assegnazioni, l’insider detiene direttamente 41.318 azioni ordinarie, oltre a 19.028 PSU e 53.671 opzioni. I premi rappresentano una tipica compensazione annuale a lungo termine, pensata per allineare la gestione agli azionisti e favorire la retention. Considerando l’ammontare di circa 1,3 miliardi di azioni di MDT, l’impatto diluitivo è trascurabile (<0,01%). Non sono state riportate vendite, quindi non è possibile inferire il sentiment di trading.
Medtronic plc (MDT) – Presentación interna Formulario 4. El 28/07/2025 la empresa otorgó premios en acciones a Harry Skip Kiil, EVP y Presidente de Cardiovascular. La presentación no muestra operaciones en el mercado abierto; todas las transacciones llevan el código “A” (premio).
- Unidades de Acciones Restringidas: 7,612 acciones ordinarias, con un 100% de consolidación en el tercer aniversario. La propiedad beneficiaria de acciones ordinarias aumenta a 41,318.
- Unidades de Acciones por Desempeño (PSU): Objetivo de 19,028 acciones (rango 0–38,056) condicionado a métricas de desempeño a tres años que concluyen el 28/04/2028.
- Opciones sobre Acciones: 53,671 opciones con precio de ejercicio de $91.97, expiran el 28/07/2035; el 25% se vuelve ejercitable cada año a partir del 28/07/2026.
Tras estas concesiones, el insider posee directamente 41,318 acciones ordinarias más 19,028 PSU y 53,671 opciones. Los premios representan una compensación anual estándar a largo plazo destinada a alinear la gestión con los accionistas y fomentar la retención. Dado el recuento aproximado de 1.3 mil millones de acciones de MDT, el impacto dilutivo es insignificante (<0.01%). No se reportaron ventas, por lo que no se puede inferir el sentimiento de negociación.
Medtronic plc (MDT) – 내부자 거래 신고서 Form 4. 2025년 7월 28일 회사는 심혈관 부문 EVP 겸 사장인 Harry Skip Kiil에게 주식 보상을 부여했습니다. 신고서에는 공개 시장 거래 없음이 표시되며, 모든 거래는 코드 “A”(수여)로 기록되어 있습니다.
- 제한 주식 단위(RSU): 7,612 보통주, 3주년 기념일에 100% 권리 확정. 보유 주식 수는 41,318주로 증가합니다.
- 성과 주식 단위(PSU): 3년 성과 지표에 따라 2028년 4월 28일에 종료되는 목표 19,028주 (0~38,056 범위).
- 스톡 옵션: 행사가 $91.97, 만료일 2035년 7월 28일인 53,671 옵션; 2026년 7월 28일부터 매년 25%씩 행사 가능.
이번 부여 후 내부자는 직접 41,318 보통주와 19,028 PSU, 53,671 옵션을 보유하게 됩니다. 이 보상은 경영진과 주주 간의 이해관계 일치를 도모하고 유지 유인을 제공하는 표준 연간 장기 인센티브입니다. MDT의 약 13억 주 주식 수를 고려할 때 희석 영향은 미미합니다(<0.01%). 매도 보고가 없어 거래 심리를 판단할 수 없습니다.
Medtronic plc (MDT) – Déclaration d’initié Formulaire 4. Le 28/07/2025, la société a attribué des actions à Harry Skip Kiil, EVP et Président Cardiovasculaire. La déclaration ne montre aucune transaction sur le marché ouvert ; toutes les opérations portent le code « A » (attribution).
- Unités d’actions restreintes : 7 612 actions ordinaires, acquises à 100 % au troisième anniversaire. La détention effective d’actions ordinaires passe à 41 318.
- Unités d’actions de performance (PSU) : Objectif de 19 028 actions (plage de 0 à 38 056) conditionné à des critères de performance sur 3 ans se terminant le 28/04/2028.
- Options d’achat d’actions : 53 671 options avec un prix d’exercice de 91,97 $, expirant le 28/07/2035 ; 25 % deviennent exerçables chaque année à partir du 28/07/2026.
Après ces attributions, l’initié détient directement 41 318 actions ordinaires ainsi que 19 028 PSU et 53 671 options. Ces récompenses constituent une compensation annuelle standard à long terme visant à aligner la direction avec les actionnaires et à encourager la rétention. Étant donné le nombre d’environ 1,3 milliard d’actions MDT, l’impact dilutif est négligeable (<0,01 %). Aucune vente n’a été signalée, il est donc impossible de déduire le sentiment du marché.
Medtronic plc (MDT) – Insider-Meldung Form 4. Am 28.07.2025 gewährte das Unternehmen Aktienprämien an Harry Skip Kiil, EVP & Präsident der Kardiovaskulären Abteilung. Die Meldung zeigt keine Transaktionen am offenen Markt; alle Vorgänge sind mit dem Code „A“ (Zuteilung) gekennzeichnet.
- Restricted Stock Units: 7.612 Stammaktien, die zu 100 % am dritten Jahrestag unverfallbar werden. Das wirtschaftliche Eigentum an Stammaktien steigt auf 41.318.
- Performance Share Units (PSUs): Zielwert 19.028 Aktien (Spanne 0–38.056), abhängig von dreijährigen Leistungskennzahlen mit Ablauf am 28.04.2028.
- Aktienoptionen: 53.671 Optionen mit einem Ausübungspreis von 91,97 $, Laufzeit bis 28.07.2035; jeweils 25 % werden jährlich ab dem 28.07.2026 ausübbar.
Nach den Zuteilungen hält der Insider direkt 41.318 Stammaktien sowie 19.028 PSUs und 53.671 Optionen. Die Prämien stellen eine übliche jährliche langfristige Anreizvergütung dar, die das Management mit den Aktionären in Einklang bringen und die Bindung fördern soll. Angesichts der etwa 1,3 Mrd. Aktien von MDT ist die Verwässerungswirkung unerheblich (<0,01 %). Es wurden keine Verkäufe gemeldet, daher lässt sich die Handelsstimmung nicht ableiten.
- Alignment of interests: Performance-based and time-vested awards encourage long-term value creation.
- No insider selling: Entire transaction consists of equity grants; no negative sell signal.
- Potential dilution: If all awards vest/exercise, 80,311 new shares could be issued, albeit immaterial relative to total shares.
Insights
TL;DR: Routine equity grant to MDT senior executive; negligible dilution and neutral fundamental impact.
The Form 4 discloses routine long-term incentive awards—RSUs, PSUs and options—to EVP Harry Kiil. The option strike of $91.97 matches the market on grant date, so value creation depends on future price appreciation. PSUs add performance conditions, tying payout to company metrics through 2028. The total shares involved (< 0.07 % of equity) are too small to alter valuation or float dynamics. With no dispositions, the filing neither signals insider confidence nor concern. I classify the filing as neutral/not impactful for investors.
Medtronic plc (MDT) – Comunicazione interna Form 4. Il 28/07/2025 la società ha assegnato premi azionari a Harry Skip Kiil, EVP e Presidente Cardiovascolare. La comunicazione non riporta operazioni sul mercato aperto; tutte le transazioni sono contrassegnate dal codice “A” (assegnazione).
- Restricted Stock Units: 7.612 azioni ordinarie, con maturazione del 100% al terzo anniversario. La proprietà effettiva delle azioni ordinarie sale a 41.318.
- Performance Share Units (PSU): Obiettivo di 19.028 azioni (intervallo 0–38.056) subordinato a metriche di performance triennali con scadenza il 28/04/2028.
- Stock Options: 53.671 opzioni con prezzo di esercizio di 91,97$, in scadenza il 28/07/2035; il 25% diventa esercitabile ogni anno a partire dal 28/07/2026.
Dopo queste assegnazioni, l’insider detiene direttamente 41.318 azioni ordinarie, oltre a 19.028 PSU e 53.671 opzioni. I premi rappresentano una tipica compensazione annuale a lungo termine, pensata per allineare la gestione agli azionisti e favorire la retention. Considerando l’ammontare di circa 1,3 miliardi di azioni di MDT, l’impatto diluitivo è trascurabile (<0,01%). Non sono state riportate vendite, quindi non è possibile inferire il sentiment di trading.
Medtronic plc (MDT) – Presentación interna Formulario 4. El 28/07/2025 la empresa otorgó premios en acciones a Harry Skip Kiil, EVP y Presidente de Cardiovascular. La presentación no muestra operaciones en el mercado abierto; todas las transacciones llevan el código “A” (premio).
- Unidades de Acciones Restringidas: 7,612 acciones ordinarias, con un 100% de consolidación en el tercer aniversario. La propiedad beneficiaria de acciones ordinarias aumenta a 41,318.
- Unidades de Acciones por Desempeño (PSU): Objetivo de 19,028 acciones (rango 0–38,056) condicionado a métricas de desempeño a tres años que concluyen el 28/04/2028.
- Opciones sobre Acciones: 53,671 opciones con precio de ejercicio de $91.97, expiran el 28/07/2035; el 25% se vuelve ejercitable cada año a partir del 28/07/2026.
Tras estas concesiones, el insider posee directamente 41,318 acciones ordinarias más 19,028 PSU y 53,671 opciones. Los premios representan una compensación anual estándar a largo plazo destinada a alinear la gestión con los accionistas y fomentar la retención. Dado el recuento aproximado de 1.3 mil millones de acciones de MDT, el impacto dilutivo es insignificante (<0.01%). No se reportaron ventas, por lo que no se puede inferir el sentimiento de negociación.
Medtronic plc (MDT) – 내부자 거래 신고서 Form 4. 2025년 7월 28일 회사는 심혈관 부문 EVP 겸 사장인 Harry Skip Kiil에게 주식 보상을 부여했습니다. 신고서에는 공개 시장 거래 없음이 표시되며, 모든 거래는 코드 “A”(수여)로 기록되어 있습니다.
- 제한 주식 단위(RSU): 7,612 보통주, 3주년 기념일에 100% 권리 확정. 보유 주식 수는 41,318주로 증가합니다.
- 성과 주식 단위(PSU): 3년 성과 지표에 따라 2028년 4월 28일에 종료되는 목표 19,028주 (0~38,056 범위).
- 스톡 옵션: 행사가 $91.97, 만료일 2035년 7월 28일인 53,671 옵션; 2026년 7월 28일부터 매년 25%씩 행사 가능.
이번 부여 후 내부자는 직접 41,318 보통주와 19,028 PSU, 53,671 옵션을 보유하게 됩니다. 이 보상은 경영진과 주주 간의 이해관계 일치를 도모하고 유지 유인을 제공하는 표준 연간 장기 인센티브입니다. MDT의 약 13억 주 주식 수를 고려할 때 희석 영향은 미미합니다(<0.01%). 매도 보고가 없어 거래 심리를 판단할 수 없습니다.
Medtronic plc (MDT) – Déclaration d’initié Formulaire 4. Le 28/07/2025, la société a attribué des actions à Harry Skip Kiil, EVP et Président Cardiovasculaire. La déclaration ne montre aucune transaction sur le marché ouvert ; toutes les opérations portent le code « A » (attribution).
- Unités d’actions restreintes : 7 612 actions ordinaires, acquises à 100 % au troisième anniversaire. La détention effective d’actions ordinaires passe à 41 318.
- Unités d’actions de performance (PSU) : Objectif de 19 028 actions (plage de 0 à 38 056) conditionné à des critères de performance sur 3 ans se terminant le 28/04/2028.
- Options d’achat d’actions : 53 671 options avec un prix d’exercice de 91,97 $, expirant le 28/07/2035 ; 25 % deviennent exerçables chaque année à partir du 28/07/2026.
Après ces attributions, l’initié détient directement 41 318 actions ordinaires ainsi que 19 028 PSU et 53 671 options. Ces récompenses constituent une compensation annuelle standard à long terme visant à aligner la direction avec les actionnaires et à encourager la rétention. Étant donné le nombre d’environ 1,3 milliard d’actions MDT, l’impact dilutif est négligeable (<0,01 %). Aucune vente n’a été signalée, il est donc impossible de déduire le sentiment du marché.
Medtronic plc (MDT) – Insider-Meldung Form 4. Am 28.07.2025 gewährte das Unternehmen Aktienprämien an Harry Skip Kiil, EVP & Präsident der Kardiovaskulären Abteilung. Die Meldung zeigt keine Transaktionen am offenen Markt; alle Vorgänge sind mit dem Code „A“ (Zuteilung) gekennzeichnet.
- Restricted Stock Units: 7.612 Stammaktien, die zu 100 % am dritten Jahrestag unverfallbar werden. Das wirtschaftliche Eigentum an Stammaktien steigt auf 41.318.
- Performance Share Units (PSUs): Zielwert 19.028 Aktien (Spanne 0–38.056), abhängig von dreijährigen Leistungskennzahlen mit Ablauf am 28.04.2028.
- Aktienoptionen: 53.671 Optionen mit einem Ausübungspreis von 91,97 $, Laufzeit bis 28.07.2035; jeweils 25 % werden jährlich ab dem 28.07.2026 ausübbar.
Nach den Zuteilungen hält der Insider direkt 41.318 Stammaktien sowie 19.028 PSUs und 53.671 Optionen. Die Prämien stellen eine übliche jährliche langfristige Anreizvergütung dar, die das Management mit den Aktionären in Einklang bringen und die Bindung fördern soll. Angesichts der etwa 1,3 Mrd. Aktien von MDT ist die Verwässerungswirkung unerheblich (<0,01 %). Es wurden keine Verkäufe gemeldet, daher lässt sich die Handelsstimmung nicht ableiten.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form
For the quarterly period ended
OR
For the transition period from to
Commission File Number:
(Exact name of registrant as specified in its charter)
|
||
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
||
(Address of principal executive offices) |
|
(Zip Code) |
(
(Registrant's telephone number, including area code)
Not applicable
(Former name, former address and former fiscal year, if changed since last report.)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
N/A |
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.☒
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).☒
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
|
☐ |
|
|
☒ |
|
|
|
|
|
|
|
|
Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
|
|
|
|
|
|
|
|
|
|
|
|
Emerging growth company |
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).☐ Yes
The number of shares outstanding of the registrant's common stock was
FORM 10-Q OF LSB INDUSTRIES, INC.
TABLE OF CONTENTS
|
|
PART I – Financial Information |
|
Page |
|
|
|
|
|
Item 1. |
|
Financial Statements |
|
3 |
|
|
|
|
|
Item 2. |
|
Management's Discussion and Analysis of Financial Condition and Results of Operations |
|
18 |
|
|
|
|
|
Item 3. |
|
Quantitative and Qualitative Disclosures About Market Risk |
|
30 |
|
|
|
|
|
Item 4. |
|
Controls and Procedures |
|
31 |
|
|
|
|
|
|
|
PART II – Other Information |
|
|
|
|
|
|
|
Item 1. |
|
Legal Proceedings |
|
34 |
|
|
|
|
|
Item 1A. |
|
Risk Factors |
|
34 |
|
|
|
|
|
Item 2. |
|
Unregistered Sales of Equity Securities and Use of Proceeds |
|
34 |
|
|
|
|
|
Item 3. |
|
Defaults Upon Senior Securities |
|
34 |
|
|
|
|
|
Item 4. |
|
Mine Safety Disclosures |
|
34 |
|
|
|
|
|
Item 5. |
|
Other Information |
|
35 |
|
|
|
|
|
Item 6. |
|
Exhibits |
|
36 |
2
PART I
FINANCIAL INFORMATION
Item 1. Financial Statements
LSB INDUSTRIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Information at June 30, 2025 is unaudited)
|
|
June 30, 2025 |
|
|
December 31, 2024 |
|
||
|
|
(In Thousands) |
|
|||||
Assets |
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
|
|
$ |
|
||
Short-term investments |
|
|
|
|
|
|
||
Accounts receivable |
|
|
|
|
|
|
||
Allowance for doubtful accounts |
|
|
( |
) |
|
|
( |
) |
Accounts receivable, net |
|
|
|
|
|
|
||
Inventories: |
|
|
|
|
|
|
||
Finished goods |
|
|
|
|
|
|
||
Raw materials |
|
|
|
|
|
|
||
Total inventories |
|
|
|
|
|
|
||
Supplies, prepaid items and other: |
|
|
|
|
|
|
||
Prepaid insurance |
|
|
|
|
|
|
||
Precious metals |
|
|
|
|
|
|
||
Supplies |
|
|
|
|
|
|
||
Other |
|
|
|
|
|
|
||
Total supplies, prepaid items and other |
|
|
|
|
|
|
||
Total current assets |
|
|
|
|
|
|
||
Property, plant and equipment, net |
|
|
|
|
|
|
||
Other assets: |
|
|
|
|
|
|
||
Operating lease assets |
|
|
|
|
|
|
||
Intangible and other assets, net |
|
|
|
|
|
|
||
Total other assets |
|
|
|
|
|
|
||
Total assets |
|
$ |
|
|
$ |
|
||
Liabilities and Stockholders' Equity |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Accounts payable |
|
|
|
|
|
|
||
Short-term financing |
|
|
|
|
|
|
||
Accrued and other liabilities |
|
|
|
|
|
|
||
Current portion of long-term debt |
|
|
|
|
|
|
||
Total current liabilities |
|
|
|
|
|
|
||
Long-term debt, net |
|
|
|
|
|
|
||
Noncurrent operating lease liabilities |
|
|
|
|
|
|
||
Other noncurrent accrued and other liabilities |
|
|
|
|
|
|
||
Deferred income taxes |
|
|
|
|
|
|
||
Commitments and contingencies (Note 5) |
|
|
|
|
|
|
||
Stockholders' equity: |
|
|
|
|
|
|
||
Common stock, $ |
|
|
|
|
|
|
||
Capital in excess of par value |
|
|
|
|
|
|
||
Retained earnings |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
Less treasury stock, at cost: |
|
|
|
|
|
|
||
Common stock, |
|
|
|
|
|
|
||
Total stockholders' equity |
|
|
|
|
|
|
||
Total liabilities and stockholders’ equity |
|
$ |
|
|
$ |
|
See accompanying notes to the unaudited condensed consolidated financial statements.
3
LSB INDUSTRIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
||||
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
|
(In Thousands, Except Per Share Amounts) |
||||||
Net sales |
|
$ |
|
$ |
|
$ |
|
$ |
Cost of sales |
|
|
|
|
||||
Gross profit |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
Selling, general and administrative expense |
|
|
|
|
||||
Other expense, net |
|
|
|
|
||||
Operating income |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
Interest expense, net |
|
|
|
|
||||
Loss (gain) on extinguishment of debt |
|
|
( |
|
|
( |
||
Non-operating other income, net |
|
( |
|
( |
|
( |
|
( |
Income before income taxes |
|
|
|
|
||||
Provision for income taxes |
|
|
|
|
||||
Net income |
|
$ |
|
$ |
|
$ |
|
$ |
|
|
|
|
|
|
|
|
|
Net income per common share: |
|
|
|
|
|
|
|
|
Basic: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
|
$ |
|
$ |
|
$ |
|
|
|
|
|
|
|
|
|
Diluted: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
|
$ |
|
$ |
|
$ |
See accompanying notes to the unaudited condensed consolidated financial statements.
4
LSB INDUSTRIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited)
|
|
Common |
|
|
Treasury |
|
|
Common |
|
|
Capital in |
|
|
Retained Earnings |
|
|
Treasury |
|
|
Total |
|
|||||||
|
|
(In Thousands) |
|
|||||||||||||||||||||||||
Balance at December 31, 2024 |
|
|
|
|
|
( |
) |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|||||
Net (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
( |
) |
|||||
Stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Vesting of equity compensation |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
— |
|
|||||
Shares withheld upon vesting |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
||||
Balance at March 31, 2025 |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|||||
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Employee stock purchase plan |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
||||||
Vesting of equity compensation |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
( |
) |
|||||
Shares withheld upon vesting |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
||||
Balance at June 30, 2025 |
|
|
|
|
|
( |
) |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Balance at December 31, 2023 |
|
|
|
|
|
( |
) |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|||||
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Purchase of common stock |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
||||
Vesting of equity compensation |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
— |
|
|||||
Shares withheld upon vesting |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
||||
Balance at March 31, 2024 |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|||||
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Purchase of common stock |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
||||
Shares issued restricted stock units |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
||||||
Vesting of equity compensation |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
— |
|
|||||
Shares withheld upon vesting |
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
( |
) |
||||
Balance at June 30, 2024 |
|
|
|
|
|
( |
) |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
( |
) |
|
$ |
|
See accompanying notes to the unaudited condensed consolidated financial statements.
5
LSB INDUSTRIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|
|
Six Months Ended June 30, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
|
|
(In Thousands) |
|
|||||
Cash flows from operating activities |
|
|
|
|
|
|
||
Net income |
|
$ |
|
|
$ |
|
||
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
||
Deferred income taxes |
|
|
|
|
|
|
||
Loss (gain) on extinguishment of debt |
|
|
|
|
|
( |
) |
|
Depreciation and amortization of property, plant and equipment |
|
|
|
|
|
|
||
Amortization of short-term investments |
|
|
|
|
|
|
||
Stock-based compensation |
|
|
|
|
|
|
||
Write-downs of property, plant and equipment |
|
|
|
|
|
|
||
Other |
|
|
|
|
|
|
||
Cash provided (used) by changes in operating assets and liabilities: |
|
|
|
|
|
|
||
Accounts receivable |
|
|
( |
) |
|
|
( |
) |
Inventories |
|
|
|
|
|
|
||
Prepaid insurance |
|
|
|
|
|
|
||
Supplies, prepaid items and other |
|
|
( |
) |
|
|
( |
) |
Accounts payable |
|
|
( |
) |
|
|
( |
) |
Accrued interest |
|
|
( |
) |
|
|
( |
) |
Other assets and other liabilities |
|
|
( |
) |
|
|
( |
) |
Net cash provided by operating activities |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
Cash flows from investing activities |
|
|
|
|
|
|
||
Expenditures for property, plant and equipment |
|
|
( |
) |
|
|
( |
) |
Proceeds from short-term investments |
|
|
|
|
|
|
||
Purchases of short-term investments |
|
|
( |
) |
|
|
( |
) |
Other investing activities |
|
|
( |
) |
|
|
|
|
Net cash provided by investing activities |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
Cash flows from financing activities |
|
|
|
|
|
|
||
Repurchases of |
|
|
( |
) |
|
|
( |
) |
Payments on other long-term debt |
|
|
( |
) |
|
|
( |
) |
Payments on short-term financing |
|
|
( |
) |
|
|
( |
) |
Acquisition of treasury stock, net |
|
|
|
|
|
( |
) |
|
Taxes paid on equity awards |
|
|
( |
) |
|
|
( |
) |
Payments of debt-related costs |
|
|
|
|
|
( |
) |
|
Net cash used by financing activities |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
||
Net (decrease) increase in cash and cash equivalents |
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
||
Cash and cash equivalents at beginning of period |
|
|
|
|
|
|
||
Cash and cash equivalents at end of period |
|
$ |
|
|
$ |
|
See accompanying notes to the unaudited condensed consolidated financial statements.
6
LSB INDUSTRIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Summary of Significant Accounting Policies
All references to “LSB Industries,” “LSB,” the “Company,” “we,” “us,” and “our” refer to LSB Industries, Inc. and its subsidiaries on a consolidated basis, except where the context makes clear that the reference is only to LSB Industries, Inc. itself and not its subsidiaries. The accompanying unaudited interim financial statements and notes of LSB have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Pursuant to such rules and regulations, certain disclosures normally included in financial statements prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) have been omitted. The accompanying unaudited condensed consolidated interim financial statements and notes should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 (our “2024 Form 10-K”), filed with the SEC on February 27, 2025. The accompanying unaudited interim financial statements in this report reflect all adjustments that are, in the opinion of management, necessary for a fair statement of the Company’s results of operations and cash flows for the three and six months ended June 30, 2025 and 2024 and the Company’s financial position as of June 30, 2025.
Basis of Consolidation – LSB Industries, Inc. and its subsidiaries are consolidated in the accompanying unaudited condensed consolidated interim financial statements. All intercompany accounts and transactions have been eliminated. Certain prior period amounts reported in our unaudited condensed consolidated interim financial statements and notes thereto have been reclassified to conform to current period presentation.
Nature of Business – We are engaged in the manufacture and sale of chemical products. The chemical products we primarily manufacture, market and sell are ammonia, fertilizer grade ammonium nitrate (“HDAN”) and urea ammonia nitrate (“UAN”) for agricultural applications, high purity and commercial grade ammonia, high purity ammonium nitrate, sulfuric acids, concentrated, blended and regular nitric acid, mixed nitrating acids, carbon dioxide, and industrial grade ammonium nitrate (“LDAN”) and ammonium nitrate (“AN”) solutions for industrial applications. We manufacture and distribute products in
Our customers include farmers, ranchers, fertilizer dealers and distributors primarily in the ranch land and grain production markets in the United States; industrial users of acids throughout the United States and parts of Canada; and explosives manufacturers in United States and other parts of North America.
Seasonality – These interim results are not necessarily indicative of results for a full year due, in part, to the seasonality of our sales of agricultural products and the timing of performing our major plant maintenance activities. Our selling seasons for agricultural products are primarily during the spring and fall planting seasons, which typically extend from March through June and from September through November.
Cash and Cash Equivalents – Investments, which consist of highly liquid investments with original maturities of three months or less, are considered cash equivalents.
Short-Term Investments – Investments, which consist of U.S. treasury securities with remaining maturity at the time of purchase greater than three months but less than 12 months, are considered short-term investments and are classified as Level 1 under the fair value hierarchy. These investments are classified as held to maturity, consistent with our intent to hold these investments to maturity. U.S. treasury bills with remaining maturity at the time of purchase of three months or less are included in cash and cash equivalents. Due to the nature of these investments as U.S. treasury securities, no impairment is anticipated. See “Note 6. Financial Instruments” for more information regarding our short-term investments.
Accounts Receivable – Substantially all of our accounts receivable consists of trade receivables from customers. We have recognized an appropriate allowance for estimated uncollectible accounts to reflect any estimate of expected credit losses. Our estimate is based on historical experience and periodic assessment, particularly on accounts that are past due (based upon the terms of the sale). Our periodic assessment is based on our best estimate of amounts that are not recoverable, which includes a present collectability review and forward-looking assessment, where applicable. We write off accounts receivable when we deem them uncollectible and record recoveries of accounts receivable previously written off when received.
Impairment of Long-Lived Assets – Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset (asset group) may not be recoverable. An asset’s fair value must be determined when the carrying amount of an asset (asset group) exceeds the estimated undiscounted future cash flows expected to result from the use of the asset (asset group) and/or its eventual disposition. If assets to be held and used are considered to be impaired, the impairment to be
7
LSB INDUSTRIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
recognized is the amount by which the carrying amounts of the assets exceed the fair values of the assets as measured by the present value of future net cash flows expected to be generated by the assets or their appraised value. In general, our asset groups are reviewed for impairment on a facility-by-facility basis (such as the Cherokee, El Dorado or Pryor Facility) unless it is determined that the asset being evaluated will generate cash flows that are independent from the rest of the facility.
In addition, if the event or change in circumstance relates to the probable sale of an asset (or group of assets), the specific asset (or group of assets) is reviewed for impairment.
For the three and six months ended June 30, 2025, we recorded asset write-downs in the amount of $
Short-Term Financing – Our short-term financing represents the short-term note related to financing of our insurance premium, which is renewed annually.
Contingencies – Certain conditions may exist which may result in a loss, but which will only be resolved when future events occur. We assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a loss has been incurred, we accrue for such contingent loss when such loss can be reasonably estimated. If the assessment indicates that a potentially material loss contingency is not probable but reasonably possible, or is probable but cannot be estimated, the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed. Estimates of potential legal fees and other directly related costs associated with contingencies are not accrued but rather are expensed as incurred. Loss contingency liabilities are included in current and noncurrent accrued and other liabilities and are based on current estimates that may be revised in the near term. In addition, we recognize contingent gains when such gains are realized or when the contingencies have been resolved (generally at the time a settlement has been reached).
Derivatives, Hedges and Financial Instruments – In order to mitigate a portion of the commodity price risk associated with natural gas, which we utilize in our manufacturing process, we periodically enter into natural gas forward contracts or volume purchase commitments. Such contracts are required to be accounted for as derivatives under applicable accounting guidance unless they are eligible for and we elect the normal purchase normal sale (“NPNS”) exception. We are eligible for the NPNS exception when these contracts provide for the purchase of natural gas that will be delivered in quantities expected to be used over a reasonable period of time in the normal course of business and are documented as such. In the event that we have natural gas derivatives that we do not elect or do not qualify for the NPNS exception, we would account for such contracts as derivatives by recognizing them in the balance sheet at fair value with changes in fair value recognized in the statement of operations. Such derivatives are not designated as hedges for accounting purposes.
Assets and liabilities measured at fair value are classified using the following hierarchy, which is based upon the transparency of inputs to the valuation as of the measurement date:
Level 1 - Valuations of contracts classified as Level 1 are based on quoted prices in active markets for identical contracts.
Level 2 - Valuations of contracts classified as Level 2 are based on quoted prices for similar contracts and valuation inputs other than quoted prices that are observable for these contracts.
Level 3 - Valuations of assets and liabilities classified as Level 3 are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement.
Leases – We are the lessee in most of the lease arrangements we enter into. We determine if an arrangement is a lease at inception or modification of a contract and classify each lease as either an operating or finance lease based on the terms of the contract. We reassess lease classification subsequent to commencement upon a change to the expected lease term or a modification to the contract. A contract contains a lease if the contract conveys the right to control the use of the identified property or equipment, explicitly or implicitly, for a period of time in exchange for consideration. Control of an underlying asset is conveyed if we obtain the rights to direct the use of and obtain substantially all of the economic benefit from the use of the underlying asset.
An operating lease asset represents our right to use the underlying asset as a lessee for the lease term and an operating lease liability represents our obligation to make lease payments arising from the lease. Currently, most of our leases are classified as operating leases and primarily relate to railcars, other equipment and office space. Our leases that are classified as finance leases primarily relate to railcars. Variable payments are excluded from the present value of lease payments and are recognized in the period in which the payment is made. Our current leases do not contain residual value guarantees. Most of our leases do not include options to extend or terminate the lease prior to the end of the term. Leases with a term of 12 months or less are not recognized in the balance sheet.
8
LSB INDUSTRIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
As a lessee, we use our incremental borrowing rate based on the lease term and other information available at the commencement date in determining the present value of lease payments. Lease expense is recognized on a straight-line basis over the applicable lease term.
From time to time when we have excess freight capacity, we may sublease a portion of our railcars fleet on a short-term basis to other parties. The income from these subleases is recorded as a component of “Other expense, net” in our condensed consolidated statements of operations. For the three and six months ended June 30, 2025, sublease income was $
As of June 30, 2025, we had an executed finance lease for railcars with lease terms greater than one year with aggregate lease payments of approximately $
Recently Issued Accounting Pronouncements
ASU 2023-06 - In October 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-06, Disclosure Improvements—Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative, which modifies the disclosure or presentation requirements of a variety of topics in the codification. Certain of the amendments represent clarifications to or technical corrections of the current requirements. For all entities, if by June 30, 2027, the SEC has not removed the applicable requirement from Regulation S-X or Regulation S-K, the pending content of the related amendment will be removed from the codification and will not become effective for any entity. These amendments should be applied prospectively. We are currently evaluating the timing and the effect of adoption of this ASU on our consolidated financial statements and related disclosures.
ASU 2023-09 - In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which focuses on income tax disclosures around effective tax rates and cash income taxes paid. This ASU will be effective for us on a prospective basis for annual periods beginning after December 15, 2024. We will adopt this ASU prospectively for the period ending December 31, 2025, and it will impact only our disclosures, with no impact to our financial condition and results of operations. We do not expect the impact of this update to be material, as the improvements are enhancements to existing disclosures in the financial statements.
ASU 2024-03 - In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. This ASU requires an entity to disclose the amounts of purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each relevant expense caption. It also requires an entity to include certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure. Additionally, it requires an entity to disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively, and to disclose the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses. The amendments in the ASU are effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027, with early adoption permitted. An entity may apply the amendments prospectively for reporting periods after the effective date or retrospectively to any or all prior periods presented in the financial statements. While this ASU will impact only our disclosures and not our financial condition and results of operations, we are currently evaluating the timing and effect of adopting this ASU.
Changes to U.S. GAAP are established by the FASB in the form of ASUs to the FASB’s Accounting Standards Codification. We considered all ASUs issued and outstanding or that became effective since January 1, 2025 through the date of these financial statements and determined them not to be applicable or materially impact our financial statements other than those ASUs specifically addressed above.
9
LSB INDUSTRIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
2. Net (Loss) Income per Common Share
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
||||||||||
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
||||
|
|
(In Thousands, Except Per Share Amounts) |
|
|||||||||||||
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Numerator for basic and diluted net |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Denominator for basic net income per common |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Effect of dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Unvested restricted stock and stock units |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Dilutive potential common shares |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Denominator for diluted net income per common |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic net income per common share |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Diluted net income per common share |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
The following securities were not included in the computation of diluted net (loss) income per common share as their effect would have been antidilutive:
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
||||
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
|
|
|
|
|
|
|
|
Restricted stock and stock units |
|
|
|
|
||||
Stock options |
|
— |
|
|
— |
|
||
|
|
|
|
|
3. Accrued and Other Liabilities
|
|
June 30, 2025 |
|
|
December 31, 2024 |
|
||
|
|
(In Thousands) |
|
|||||
Accrued interest |
|
$ |
|
|
$ |
|
||
Customer deposits |
|
|
|
|
|
|
||
Current portion of operating lease liabilities |
|
|
|
|
|
|
||
Accrued payroll and benefits |
|
|
|
|
|
|
||
Other |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
Less noncurrent portion |
|
|
|
|
|
|
||
Current portion of accrued and other liabilities |
|
$ |
|
|
$ |
|
10
LSB INDUSTRIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
4. Long-Term Debt
Our long-term debt consists of the following:
|
|
June 30, 2025 |
|
|
December 31, 2024 |
|
||
|
|
(In Thousands) |
|
|||||
Revolving Credit Facility (A) |
|
$ |
— |
|
|
$ |
— |
|
Senior Secured Notes due 2028, with an interest rate of |
|
|
|
|
|
|
||
Secured Financing due 2025, with an interest rate of |
|
|
|
|
|
|
||
Finance Leases (D) |
|
|
|
|
|
|
||
Unamortized debt issuance costs (1) |
|
|
( |
) |
|
|
( |
) |
|
|
|
|
|
|
|
||
Less current portion of long-term debt |
|
|
|
|
|
|
||
Long-term debt due after one year, net |
|
$ |
|
|
$ |
|
_____________________________
The Revolving Credit Facility matures on
LSB Industries, Inc. and all of its subsidiaries (collectively, the “Borrowers”) are co-borrowers under the Revolving Credit Facility. Obligations under the Revolving Credit Facility are secured by a first priority security interest in substantially all of our current assets, including accounts receivable and inventory, subject to certain exceptions.
The Revolving Credit Facility contains a financial covenant, which requires that, solely if we elect to remove the Availability Block, then
During the three months ended June 30, 2025, we repurchased $
During the three months ended June 30, 2024, we repurchased $
11
LSB INDUSTRIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
During the six months ended June 30, 2024, we repurchased $
5. Commitments and Contingencies
Outstanding Natural Gas Purchase Commitments – Certain of our natural gas contracts qualify as normal purchases under U.S. GAAP and thus are not financial instruments for which we mark-to-market. At June 30, 2025, we did not have material volumes of natural gas under fixed price contracts.
Legal Matters - Following is a summary of certain legal matters involving the Company:
A. Environmental Matters
Our facilities and operations are subject to numerous federal, state and local environmental laws and to other laws regarding health and safety matters (collectively, the “Environmental and Health Laws”), many of which provide for certain performance obligations, substantial fines and criminal sanctions for violations. Certain Environmental and Health Laws impose strict liability as well as joint and several liability for costs required to remediate and restore sites where hazardous substances, hydrocarbons or solid wastes have been stored or released. We may be required to remediate contaminated properties currently or formerly owned or operated by us or facilities of third parties that received waste generated by our operations regardless of whether such contamination resulted from the conduct of others or from consequences of our own actions that were in compliance with all applicable laws at the time those actions were taken.
In addition, claims for damages to persons or property, including natural resources, may result from the environmental, health and safety effects of our operations.
There can be no assurance that we will not incur material costs or liabilities in complying with such laws or in paying fines or penalties for violation of such laws. Our insurance may not cover all environmental risks and costs or may not provide sufficient coverage if an environmental claim is made against us. The Environmental and Health Laws and related enforcement policies have in the past resulted, and could in the future result, in significant compliance expenses, cleanup costs (for our sites or third-party sites where our wastes were disposed of), penalties or other liabilities relating to the handling, manufacture, use, emission, discharge or disposal of hazardous or toxic materials at or from our facilities or the use or disposal of certain of its chemical products. Further, a number of our facilities are dependent on environmental permits to operate, the loss or modification of which could have a material adverse effect on their operations and our financial condition.
Historically, we have incurred significant capital expenditures in order to comply with the Environmental and Health Laws and significant capital expenditures are expected to be incurred in the future. We will also be obligated to manage certain discharge water outlets and monitor groundwater contaminants at our facilities should we discontinue the operations of a facility.
As of June 30, 2025, our accrued liabilities for environmental matters totaled approximately $
1. Discharge Water Matters
Each of our manufacturing facilities generates process wastewater, which may include cooling tower and boiler water quality control streams, contact storm water and miscellaneous spills and leaks from process equipment. The process water discharge, storm-water runoff and miscellaneous spills and leaks are governed by various permits generally issued by the respective state environmental agencies as authorized and overseen by the U.S. Environmental Protection Agency (the “EPA”). These permits limit the type and volume of effluents that can be discharged and control the method of such discharge.
In 2017, the Company filed a Permit Renewal Application for its Non-Hazardous Injection Well Permit at the Pryor Facility. Although the Injection Well Permit expired in 2018, we continue to operate the injection well in accordance with an executed November 2023 Consent Order with the Oklahoma Department of Environmental Quality (“ODEQ”) that allows for the continued use of the injection
12
LSB INDUSTRIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
well until a wastewater treatment process is designed, built and operational. The Company continues to work with the ODEQ under the terms of the Consent Order. We have identified and selected a wastewater treatment technology using biological processes that can and will treat the nitrogen-containing wastewater streams at our Pryor Facility. We are unable to estimate the costs related to the replacement of the disposal well at this time as we are in the early stages of design for the wastewater treatment process with a wastewater process design engineering firm. We have also commenced preliminary discussions with the ODEQ on permitting the treated wastewater discharges, but have not received any confirmation from the ODEQ on their preliminary acceptance of our treated wastewater stream.
In 2006, the Company entered into a Consent Administrative Order (“CAO”) that recognizes the presence of nitrate contamination in the shallow groundwater at our El Dorado Facility. The CAO required us to perform semi-annual groundwater monitoring, continue operation of a groundwater recovery system, submit a human health and ecological risk assessment and submit a remedial action plan. The risk assessment was submitted in 2007. In 2015, the Arkansas Department of Environmental Quality (“ADEQ”) stated that the El Dorado Facility was meeting the requirements of the CAO and should continue semi-annual monitoring. A CAO was signed in 2018, which required an Evaluation Report of the data and effectiveness of the groundwater remedy for nitrate contamination. During 2019, the Evaluation Report was submitted to the ADEQ and the ADEQ approved the report. In August 2023, the Company received a Notice of Violation (“NOV”) for wastewater discharges from our El Dorado Facility. We have been in discussions with the ADEQ about our response to the NOV. The ADEQ provided notice of the cash penalty amount related to the NOV, which was accrued as of June 30, 2025 and was not material.
2. Other Environmental Matters
In 2002, certain of our subsidiaries sold substantially all of their operating assets relating to a Kansas chemical facility (the “Hallowell Facility”) but retained ownership of the real property where the facility is located. Our subsidiary retained the obligation to be responsible for and perform the activities under a previously executed consent order to investigate the surface and subsurface contamination at the real property, develop a corrective action strategy based on the investigation and implement such strategy. In addition, certain of our subsidiaries agreed to indemnify the buyer of such assets for these environmental matters.
As the successor to a prior owner of the Hallowell Facility, Chevron Environmental Management Company (“Chevron”) has agreed in writing, within certain limitations, to pay and has been paying one-half of the costs of the investigation and interim measures relating to this matter as approved by the Kansas Department of Health and Environment (the “KDHE”), subject to reallocation.
During this process, our subsidiary and Chevron retained an environmental consultant that prepared and performed a corrective action study work plan as to the appropriate method to remediate the Hallowell Facility. During 2020, the KDHE selected a remedy of annual monitoring and the implementation of an Environmental Use Control (“EUC”). This remedy primarily relates to long-term surface and groundwater monitoring to track the natural decline in contamination and is subject to a periodic review with the KDHE. At this time there is no review scheduled.
The final remedy, including the EUC, the finalization of the cost estimates and any required financial assurances remains under discussion with the KDHE. Pending the results from our discussions regarding the final remedy, we continue to accrue our allocable portion of costs primarily for the additional testing, monitoring and risk assessments that could be reasonably estimated, which amount is included in our accrued liabilities for environmental matters discussed above. The estimated amount is not discounted to its present value. As more information becomes available, our estimated accrual will be refined, as necessary.
We received a NOV for ten findings identified from an inspection conducted by the EPA Region IV at our Cherokee Facility in late 2022. We provided written responses to each finding in the inspection report issued in connection with such inspection and to the Notice of Potential Violations and held direct communications with the EPA related to the matter. A meeting was held with the EPA in January 2024 to discuss the NOV and our subsequent responsive actions. During the meeting, the EPA proposed two alternatives for the penalties related to the violations. We accepted one of the proposed alternatives, which included a cash fine that has been paid and an investment in a community project, for which we accrued an estimate as of December 31, 2023.
B. Other Pending, Threatened or Settled Litigation
In addition to the foregoing, we are also involved in various other claims and legal actions (including matters involving gain contingencies) in the ordinary course of our business. While it is possible that the actual claims results could differ from our estimates, after consultation with legal counsel, we believe that any such differences will not have a material effect on our business, financial condition, results of operations or cash flows.
13
LSB INDUSTRIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
6. Financial Instruments
Natural Gas Contracts
Periodically, we enter into certain forward natural gas contracts or volume purchase commitments, which are derivatives. We utilize these natural gas contracts as economic hedges for risk management purposes but the contracts are not designated as hedging instruments. At June 30, 2025 and December 31, 2024, we had
Financial Instruments
At June 30, 2025 and December 31, 2024, we did
|
|
June 30, 2025 |
|
|
December 31, 2024 |
|
||||||||||
|
|
Carrying |
|
|
Estimated |
|
|
Carrying |
|
|
Estimated |
|
||||
|
|
Amount |
|
|
Fair Value |
|
|
Amount |
|
|
Fair Value |
|
||||
|
|
(In Millions) |
|
|||||||||||||
Senior Secured Notes (1) |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Short-Term Investments |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
_____________________________
7. Income Taxes
Provision for income taxes is as follows:
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
||||||||||
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
||||
|
|
(In Thousands) |
|
|||||||||||||
Current: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Federal |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
State |
|
|
|
|
|
( |
) |
|
|
|
|
|
( |
) |
||
Total Current |
|
$ |
|
|
$ |
( |
) |
|
$ |
|
|
$ |
( |
) |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Deferred: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Federal |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
State |
|
|
|
|
|
( |
) |
|
|
( |
) |
|
|
( |
) |
|
Total Deferred |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Provision for income taxes |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
The tax provision for the six months ended June 30, 2025, was $
We considered both positive and negative evidence in our determination of the need for valuation allowances for deferred tax assets. Information evaluated includes our financial position and results of operations for the current and preceding years, the availability of deferred tax liabilities and tax carrybacks, as well as an evaluation of currently available information about future years. Valuation allowances are reflective of our quarterly analysis of the four sources of taxable income, including the calculation of the reversal of existing tax assets and liabilities, the impact of financing activities and our quarterly results. Based on our analysis, we have determined that it is more-likely-than-not that all of our federal deferred tax assets and a portion of our state deferred tax assets will be utilized. We estimate an approximately $
We will continue to evaluate both the positive and negative evidence on a quarterly basis in determining the need for a valuation allowance with respect to our deferred tax assets. Changes in positive and negative evidence, including differences between estimated
14
LSB INDUSTRIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
and actual results, could result in changes in the valuation of our deferred tax assets that could have a material impact on our consolidated financial statements. Changes in existing tax laws could also affect actual tax results and the realization of deferred tax assets over time.
LSB Industries, Inc. and certain of its subsidiaries file income tax returns in the U.S. federal jurisdiction and various state jurisdictions. With few exceptions, the 2021-2024 years remain open for all purposes of examination by the U.S. Internal Revenue Service (“IRS”) and other major tax jurisdictions. Additionally, the 2013-2020 years remain subject to examination for determining the amount of net operating loss and other carryforwards.
On July 4, 2025, “An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14” and commonly referred to as the One Big Beautiful Bill Act (“OBBBA”) was enacted into law in the United States. The OBBBA includes significant provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and favorable changes to bonus depreciation, domestic research cost expensing, and the business interest limitation. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. We are still evaluating its impact on our financial statements.
8. Net Sales
Disaggregated Net Sales
We primarily derive our revenues from the sales of various chemical products. The Company’s net sales disaggregation is consistent with other financial information utilized or provided outside of our condensed consolidated financial statements. Accordingly, this approach is reflected in disaggregated net sales, mirroring how the Company manages its net sales by product through contracts with customers.
The following table presents our net sales disaggregated by our products, which disaggregation is consistent with other financial information utilized or provided outside of our consolidated financial statements:
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
||||||||||
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
||||
|
|
(In Thousands) |
|
|||||||||||||
Net sales: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
AN & Nitric Acid |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
||||
Urea ammonium nitrate (UAN) |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Ammonia |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Other |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Total net sales |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
Other Information
Liabilities associated with contracts with customers (contract liabilities) primarily relate to deferred revenue and customer deposits associated with cash payments received in advance from customers for product shipments. We had approximately $
For most of our contracts with customers, the transaction price from the inception of a contract is constrained to a short period of time (generally one month) as these contracts contain terms with variable consideration related to both price and quantity. At June 30, 2025, we have remaining performance obligations with certain customer contracts, excluding contracts with original durations of less than one year and for service contracts for which we have elected the practical expedient for consideration recognized in revenue as invoiced. As of June 30, 2025, the remaining performance obligations totaled approximately $
15
LSB INDUSTRIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
9. Related Party Transactions
As of June 30, 2025, we had one outstanding financing arrangement with an affiliate of Eldridge as discussed in footnote (C) of Note 4.
10. Supplemental Cash Flow Information
The following provides additional information relating to cash flow activities:
|
|
Six Months Ended June 30, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
|
|
(In Thousands) |
|
|||||
Cash payments (refunds) for: |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
Interest on long-term debt and other, net of capitalized interest |
|
$ |
|
|
$ |
|
||
Income taxes, net |
|
$ |
|
|
$ |
|
||
|
|
|
|
|
|
|
||
Noncash investing and financing activities: |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
Property, plant and equipment acquired and not yet paid at end of period |
|
$ |
|
|
$ |
|
||
Loss (gain) on extinguishment of debt |
|
$ |
|
|
$ |
( |
) |
|
Accounts payable associated with debt-related costs |
|
$ |
— |
|
|
$ |
|
16
LSB INDUSTRIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
11. Segment
The Company is managed on a consolidated basis with a single reportable segment, chemical manufacturing, which is not an aggregation of individual operating segments. There have been no changes in the basis of segmentation or in the basis of measurement of segment profit or loss since the filing of our 2024 Form 10-K.
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
||||
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
|
(In Thousands) |
||||||
Net sales |
|
$ |
|
$ |
|
$ |
|
$ |
Less: |
|
|
|
|
|
|
|
|
Cost of sales excluding depreciation, amortization |
|
|
|
|
||||
Depreciation and amortization |
|
|
|
|
||||
Turnaround expense |
|
|
|
|
||||
Total cost of sales |
|
|
|
|
||||
Selling, general and administrative |
|
|
|
|
|
|
|
|
Wages and benefits |
|
|
|
|
||||
Other selling general and administrative |
|
|
|
|
||||
Total selling general and administrative |
|
|
|
|
||||
Interest expense |
|
|
|
|
||||
Loss (gain) on extinguishments of debt |
|
|
( |
|
59 |
|
( |
|
Loss from asset write-down and disposals |
|
|
|
|
||||
Income tax provision |
|
|
|
|
||||
Other segment items (a) |
|
( |
|
( |
|
( |
|
( |
Segment net income |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
Reconciliation of profit or loss |
|
|
|
|
|
|
|
|
Adjustments and reconciling items |
|
|
|
|
||||
Consolidated net income |
|
$ |
|
$ |
|
$ |
|
$ |
_____________________________
(a) For the periods presented, amount consisted primarily of interest and sublease income.
The measure of our chemical manufacturing segment assets is reported on the condensed consolidated balance sheet as total assets. Expenditures for long-lived chemical manufacturing segment assets are reported on our condensed consolidated statement of cash flows.
17
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
This discussion is intended to provide a reader of our financial statements with management’s perspective on our financial condition, results of operations, liquidity, and certain other factors that may affect our future results. Investors should read the following discussion and analysis in conjunction with the consolidated financial statements and related notes included in “Item 1. Financial Statements.” Notes referenced in this discussion and analysis refer to the notes to consolidated financial statements that are found in “Item 1. Financial Statements—Notes to Condensed Consolidated Financial Statements.” Certain statements contained in this discussion may be deemed to be forward-looking statements. See “Special Note Regarding Forward-Looking Statements.” Actual results could differ materially from those discussed in or implied by forward-looking statements as a result of various factors, including those discussed below and in our Annual Report on Form 10-K for the year ended December 31, 2024, particularly in the section entitled “Risk Factors.” Unless we state otherwise or the context otherwise requires, the terms “we,” “us,” “our” and the “Company” refer to LSB Industries, Inc. and its consolidated subsidiaries.
Overview
General
LSB is headquartered in Oklahoma City, Oklahoma and we manufacture and sell chemical products for the agricultural and industrial markets. We own and operate three multi-plant facilities in Cherokee, Alabama (the “Cherokee Facility”), El Dorado, Arkansas (the “El Dorado Facility”) and Pryor, Oklahoma (the “Pryor Facility”) and operate a facility on behalf of Covestro LLC in Baytown, Texas. Our products are sold through distributors and directly to end customers primarily throughout the United States and other parts of North America.
Key Operating Initiatives for 2025
We expect our future results of operations and financial condition to benefit from the following key initiatives:
Low carbon ammonia is produced using natural gas and conventional processes but includes an additional stage where the carbon dioxide emissions are captured and permanently stored in deep underground rock formations. We believe that the resulting low carbon emission product can be sold at a premium to conventional ammonia, to customers seeking to reduce their carbon footprint, particularly in the power generation, marine, industrial, mining and agricultural end markets.
18
Additionally, we believe that producers of low carbon ammonia will be eligible for government incentives aimed at promoting carbon capture and sequestration (“CCS”).
We believe we are well-positioned to capitalize on this opportunity given our potential to retrofit our existing plants, which we believe can reduce our time to market for low carbon ammonia and also reduce the upfront capital expenditures necessary to enable us to produce this product. We are currently pursuing projects that could enable us to become a producer and marketer of low carbon ammonia and other derivative products. These projects include a low carbon ammonia project at our El Dorado Facility in collaboration with Lapis Carbon Solutions (“Lapis”) that we expect to be operational by the end of 2026. In January 2025, we achieved pre-certification status under the Fertilizer Institute’s Verified Ammonia Carbon Intensity program. This is a voluntary certification of the carbon footprint of ammonia production at a specific facility, from well to production gate. Our El Dorado ammonia plant is one of four North American plants to have received such a status.
Recent Business Developments
Advanced Low Carbon Ammonia Initiatives
In May 2024, we announced an agreement to supply, for a five-year period commencing January 1, 2025, up to 150,000 short tons per year of low carbon ammonium nitrate solution (“ANS”) to Freeport Minerals Corporation (“Freeport”). In early 2025 we began supplying conventional ANS to Freeport from our El Dorado Facility, and expect to phase in the low carbon contracted volume in the next year. Freeport intends to use the low carbon ANS purchased from us for its United States copper mining operations.
In April 2022, we entered into an agreement with Lapis to develop a project to capture and sequester CO2 at our El Dorado Facility. Lapis, backed by Cresta Fund Management, a Dallas-based middle-market infrastructure investment firm, will invest the majority of the capital required for project development. The project is expected to be completed and operational by the end of 2026, subject to the approval of a Class VI permit, at which time CO2 injections are expected to begin. Once operational, the project at the El Dorado site will initially capture and sequester approximately 400,000 to 500,000 metric tons of CO2 per year in underground saline aquifers.
The sequestered CO2 generated from the facility’s ammonia production is expected to qualify for federal tax credits under Internal Revenue Code Section 45Q, which are $85 per metric ton of CO2 captured and sequestered. Lapis, as the majority owner of the CCS equipment, will earn the 45Q tax credits and will pay us a fee for each ton of CO2 captured and sequestered by the end of 2026. Once in operation, the sequestered CO2 is expected to reduce our overall scope 1 GHG emissions by approximately 25% from current levels. In addition, sequestering approximately 400,000 to 500,000 metric tons of CO2 annually is expected to enable us to produce approximately 305,000 to 380,000 metric tons of low carbon ammonia annually, a product that could potentially be sold at higher price levels than conventional ammonia. In February 2023, a key milestone was achieved in the advancement of our low carbon ammonia project at El Dorado by filing a pre-construction Class VI permit application with the United States Environmental Protection Agency (the “EPA”). The EPA recognized the application as complete in March 2023 and is currently in the review process. In June 2025, Lapis completed the drilling of a stratigraphic injection well at the El Dorado site and has been gathering data
19
to support the EPA in its continuing technical review of our Class VI application. Once the project receives EPA approval, we intend to use this well for CO2 injections.
Higher UAN Prices and Higher AN and UAN Sales Volumes Offset by Higher Natural Gas Input Costs
Second quarter 2025 results were impacted by natural gas input costs, which were higher than they were in the second quarter and full year of 2024. Partially offsetting the impact of higher natural gas prices were increased sales volumes of AN and UAN. Additionally, second quarter 2025 results benefited from higher UAN prices relative to the prior year second quarter.
Ammonia prices currently reflect reduced supply from the Middle East, robust demand in the United States, and higher cost of production in Europe. Global ammonia inventories appear balanced, however, and as the year progresses, pricing may be impacted by the start-up of new production capacity in both the United States and internationally, with at least one new world scale plant expected to come online during 2025.
Pricing for ammonia derivative fertilizer products has been strong. Both urea and UAN prices are currently well above year-ago levels, reflecting a variety of factors including tight global supply with limited inventory in the United States distribution channel; the demand pull of a strong Spring 2025 corn planting season with the United States Department of Agriculture (“USDA”) currently expecting 95 million acres of corn to be planted, up 5% from the 2024 planting season; and a reduced pace of import flow into the United States.
Demand for our industrial products is stable despite global economic concerns. Nitric acid demand has been steady, reflecting the resilience of the U.S. economy and consumer spending levels. Demand for AN for use in mining applications has been bolstered by positive exposure to copper, gold and iron ore, as well as continued attractive market fundamentals for aggregate production relating to infrastructure construction. Economic uncertainty continues to be heightened by the potential impacts of tariffs on global trade flows, consumer prices and production input costs. However, we believe that we have a meaningful degree of downside protection in our industrial business given our diverse customer base which is almost entirely located in the United States, the nature of our contracts and our ability to shift our production mix to products where demand and pricing are strongest.
See a more detailed discussion below under “Key Industry Factors.”
Shift in Production Mix
Over the last several months, we commenced the process of transitioning our production of HDAN, an agricultural/fertilizer product, to ANS, a product used in industrial and mining applications. We expect this transition to be complete and production of HDAN to cease later in the third quarter of 2025. This transition is consistent with our strategy to shift a portion of our sales mix from agricultural sales made at spot market pricing, which can be volatile, towards sales covered under multi-year contracts where we pass through the cost of natural gas feedstock. With the discontinuation of HDAN production, we will also close our agricultural retail location in Elkhart, TX, as its primarily purpose was to sell the HDAN we produced. The process to close this retail location commenced at the beginning of the third quarter of 2025 and will be substantially complete by quarter-end.
Key Industry Factors
Supply and Demand
Fertilizer
The price at which our agricultural products are ultimately sold depends on numerous factors, including the supply and demand for nitrogen fertilizers which, in turn, depends upon world grain demand and production levels, the cost and availability of transportation and storage, weather conditions, competitive pricing and the availability of imports. Additionally, expansions or upgrades of competitors’ facilities and international and domestic political and economic developments continue to play an important role in the global nitrogen fertilizer industry economics. These factors can affect, in addition to selling prices, the level of inventories in the market which can cause price volatility and affect product margins.
From a farmer’s perspective, the demand for fertilizer is affected by the aggregate crop planting decisions including farm economics, weather and fertilizer application rate decisions of individual farmers. Individual farmers make planting decisions based largely on prospective profitability of a harvest, while the specific varieties and amounts of fertilizer they apply depend on factors such as their financial resources, soil conditions, weather patterns and the types of crops planted.
Additionally, changes in corn prices, as well as soybean, cotton and wheat prices, can affect the number of acres of corn planted in a given year and the number of acres planted will drive the level of nitrogen fertilizer consumption, likely affecting prices.
According to the World Agricultural Supply and Demand Estimates Report dated July 11, 2025 (the “July Report”), farmers planted approximately 95.2 million acres of corn in the 2025 planting season, up 5.1% compared to the 2024 planting season. According to the July Report, the USDA estimates the United States ending stocks for the 2025 Harvest will be approximately 42.2 million metric tons, a 24.1% increase from the 2024 Harvest. The USDA's expected yield per acre for the 2025 Harvest is 181.0 bushels, up approximately 0.9% from a year ago.
20
The following July 2025 estimates are associated with the corn market:
|
|
2026 Crop |
|
|
2025 Crop |
|
|
|
|
2024 Crop |
|
|
|
|
|||||
|
|
(2025 Harvest) |
|
|
(2024 Harvest) |
|
|
Percentage |
|
(2023 Harvest) |
|
|
Percentage |
|
|||||
|
|
July Report (1) |
|
|
July Report (1) |
|
|
Change (2) |
|
July Report (1) |
|
|
Change (3) |
|
|||||
U.S. Area Planted (Million acres) |
|
|
95.2 |
|
|
|
90.6 |
|
|
|
5.1 |
% |
|
94.6 |
|
|
|
0.6 |
% |
U.S. Yield per Acre (Bushels) |
|
|
181.0 |
|
|
|
179.3 |
|
|
|
0.9 |
% |
|
177.3 |
|
|
|
2.1 |
% |
U.S. Production (Million bushels) |
|
|
15,705 |
|
|
|
14,867 |
|
|
|
5.6 |
% |
|
15,341 |
|
|
|
2.4 |
% |
U.S. Ending Stocks (Million metric tons) |
|
|
42.2 |
|
|
|
34.0 |
|
|
|
24.1 |
% |
|
44.8 |
|
|
|
(5.8 |
%) |
World Ending Stocks (Million metric tons) |
|
|
272.1 |
|
|
|
284.2 |
|
|
|
(4.3 |
%) |
|
315.7 |
|
|
|
(13.8 |
%) |
The current USDA corn outlook for the United States calls for smaller supplies, domestic use, and ending stocks. Corn beginning stocks are down reflecting an increase in exports partly offset by lower feed and residual use. With supply falling more than use, ending stocks are down 90 million bushels from the previous month’s report. From a demand perspective, we believe that corn prices will remain at a level that will further support demand for fertilizers during the remainder of 2025.
Industrial Products
Our industrial products sales volumes are dependent upon general economic conditions, primarily in the housing, automotive and paper industries. Demand for our industrial products is stable despite persistent global economic challenges. Nitric acid demand has been steady, reflecting the strength of the U.S. economy and consumer spending levels. Our sales prices generally vary with the market price of ammonia or natural gas, as applicable, in our pricing arrangements with customers.
Our LDAN and AN solution, which are primarily used as AN fuel oil and specialty emulsions for usage in the quarry and the construction industries, are used for metals mining and to a lesser extent, for coal. Demand for AN for use in mining applications has been bolstered by positive exposure to copper, gold and iron ore, as well as continued attractive market fundamentals for aggregate production relating to infrastructure construction. Economic uncertainty has recently been heightened by the potential impacts of tariffs on global trade flows, consumer prices and production input costs. However, we believe that we have a meaningful degree of downside protection in our industrial business given our diverse customer base which is almost entirely located in the United States, the nature of our contracts and our ability to shift our production mix to products where demand and pricing are strongest.
Natural Gas Prices
Natural gas is the primary feedstock used to produce nitrogen fertilizers at our manufacturing facilities. In recent years, U.S. natural gas reserves have increased significantly due to, among other factors, advances in extracting shale gas, which has reduced and stabilized natural gas prices, providing North America with a cost advantage over certain imports. As a result, our competitive position and that of other North American nitrogen fertilizer producers has been positively affected.
We historically have purchased natural gas either on the spot market, through forward purchase contracts, or a combination of both and we have used forward purchase contracts to lock in pricing for a portion of our natural gas requirements. These forward purchase contracts are generally either fixed-price or index-price, short-term in nature and for a fixed supply quantity. We are able to purchase natural gas at competitive prices due to our connections to large distribution systems and their proximity to interstate pipeline systems.
The following table shows the volume of natural gas purchased and the average cost per MMBtu:
|
|
Three Months Ended June 30, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Natural gas volumes (MMBtu in millions) |
|
|
7.8 |
|
|
|
7.5 |
|
Natural gas average cost per MMBtu |
|
$ |
3.37 |
|
|
$ |
1.92 |
|
21
Transportation Costs
Costs for transporting nitrogen-based products can be significant relative to their selling price. We continue to evaluate the rising costs of freight domestically. As a result of increases in demand for available rail, truck and barge options to transport product, primarily during the spring and fall planting seasons, higher transportation costs have and could continue to impact our margins, where we are unable to fully pass through these costs to our customers. Additionally, truck driver shortages could impact our ability to fulfill customer demand. As a result, we continue to evaluate supply chain efficiencies to reduce or counter the impact of higher logistics costs.
Key Operational Factors
Facility Reliability
Consistent, reliable and safe operations at our chemical plants are critical to our financial performance and results of operations. The financial effects of planned downtime at our plants, including a planned major maintenance activity (each such activity, a “Turnaround”) is mitigated through a diligent planning process that considers the availability of resources to perform the needed maintenance and other factors. Unplanned downtime of our plants typically results in lost contribution margin from lost sales of our products, lost fixed cost absorption from lower production of our products and increased costs related to repairs and maintenance. All Turnarounds result in lost contribution margin from lost sales of our products, lost fixed cost absorption from lower production of our products and increased costs related to repairs and maintenance, which repair and maintenance costs are expensed as incurred.
The next ammonia plant Turnaround is currently planned for our El Dorado Facility in the first half of 2026. We completed Turnarounds at both our Pryor Facility and Cherokee Facility in the latter half of 2024. Following those Turnarounds, the next Pryor Facility Turnaround is currently planned for 2027, with the Cherokee Facility Turnaround currently planned for 2028.
Ammonia Production
Ammonia is the basic product used to produce all of our upgraded products. The ammonia production rates of our plants affect the total cost per ton of each product produced and the overall sales of our products. For 2025, we are targeting total ammonia production of approximately 820,000 tons to 850,000 tons.
Forward Sales Contracts
In certain instances, we may use forward sales of our fertilizer products to optimize our asset utilization, planning process and production scheduling. These sales are made by offering customers the opportunity to purchase product on a forward basis at prices and delivery dates that are agreed upon, with delivery dates typically occurring within 12 months. We use this program to varying degrees during the year depending on market conditions and our view of changing price environments. Fixing the selling prices of our products months in advance of their ultimate delivery to customers typically causes our reported selling prices and margins to differ from spot market prices and margins available at the time of shipment.
Consolidated Results of the Second Quarter of 2025
Our consolidated net sales for the second quarter of 2025 were $151.3 million compared to $140.1 million for the same period in 2024. Our consolidated operating income for the second quarter of 2025 was $10.5 million compared to $14.4 million for the same period in 2024. The items impacting our operating results are discussed in more detail below and under “Results of Operations.”
Items Affecting Comparability of Results of the Second Quarter
Selling Prices
For the second quarter of 2025, average selling prices for ammonia and UAN increased while the average selling price for AN and nitric acids decreased compared to the second quarter of 2024.
(Loss) Gain on Extinguishment of Senior Secured Notes
During the second quarter of 2025 we repurchased $32.4 million in principal amount of our Senior Secured Notes due 2028 (“Senior Secured Notes”) for approximately $32.1 million, which was accounted for as an extinguishment of debt. Including our write-off of the associated remaining portion of unamortized debt issuance costs, we recognized a loss on extinguishment of debt of approximately $0.1 million.
During the second quarter of 2024 we repurchased $63.7 million in principal amount of our Senior Secured Notes for approximately $60.9 million. Including our write-off of the associated remaining portion of unamortized debt issuance costs, we recognized a gain on extinguishment of debt of approximately $1.9 million.
22
Plant, Property and Equipment Impairments
For the three months ended June 30, 2025 and 2024, we recorded asset write-downs primarily related to assets no longer in use in the amount of $2.5 million and $1.5 million, respectively. These write-downs are included in “Other expense, net” on our condensed consolidated statements of operations.
Results of Operations
The following is a discussion and analysis of our condensed consolidated results of operations for the three months ended June 30, 2025 and 2024.
Net sales to unaffiliated customers are reported in the condensed consolidated financial statements and gross profit represents net sales less cost of sales. Net sales are reported on a gross basis with the cost of freight being recorded in cost of sales.
Three Months Ended June 30, 2025 Compared to Three Months Ended June 30, 2024
The following table sets forth certain financial information for the three months ended June 30, 2025 and 2024, the increase or decrease between those periods, and the percentage increase or decrease between those periods with respect to each line item:
|
|
Three Months Ended June 30, |
|
|
|
|
|
Percentage |
|
|||||||
|
|
2025 |
|
|
2024 |
|
|
Change |
|
|
Change |
|
||||
|
|
(Dollars In Thousands) |
|
|
|
|
||||||||||
Net sales: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
AN & Nitric Acid |
|
$ |
61,707 |
|
|
$ |
58,442 |
|
|
$ |
3,265 |
|
|
|
6 |
% |
Urea ammonium nitrate (UAN) |
|
|
52,262 |
|
|
|
42,808 |
|
|
|
9,454 |
|
|
|
22 |
% |
Ammonia |
|
|
26,830 |
|
|
|
28,448 |
|
|
|
(1,618 |
) |
|
|
(6 |
)% |
Other |
|
|
10,497 |
|
|
|
10,375 |
|
|
|
122 |
|
|
|
1 |
% |
Total net sales |
|
$ |
151,296 |
|
|
$ |
140,073 |
|
|
$ |
11,223 |
|
|
|
8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Gross profit: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Adjusted gross profit (1) |
|
$ |
46,429 |
|
|
$ |
49,608 |
|
|
$ |
(3,179 |
) |
|
|
(6 |
)% |
Depreciation and amortization (2) |
|
|
(20,617 |
) |
|
|
(18,754 |
) |
|
|
(1,863 |
) |
|
|
10 |
% |
Turnaround expense |
|
|
(2,639 |
) |
|
|
(3,439 |
) |
|
|
800 |
|
|
|
(23 |
)% |
Total gross profit |
|
|
23,173 |
|
|
|
27,415 |
|
|
|
(4,242 |
) |
|
|
(15 |
)% |
Selling, general and administrative expense |
|
|
9,844 |
|
|
|
11,547 |
|
|
|
(1,703 |
) |
|
|
(15 |
%) |
Other expense, net |
|
|
2,836 |
|
|
|
1,465 |
|
|
|
1,371 |
|
|
N/M |
|
|
Operating income |
|
|
10,493 |
|
|
|
14,403 |
|
|
|
(3,910 |
) |
|
|
(27 |
)% |
Interest expense, net |
|
|
7,886 |
|
|
|
8,385 |
|
|
|
(499 |
) |
|
|
(6 |
)% |
Loss (gain) on extinguishment of debt |
|
|
59 |
|
|
|
(1,879 |
) |
|
|
1,938 |
|
|
N/M |
|
|
Non-operating other income, net |
|
|
(1,542 |
) |
|
|
(2,908 |
) |
|
|
1,366 |
|
|
|
(47 |
)% |
Provision for income taxes |
|
|
1,084 |
|
|
|
1,250 |
|
|
|
(166 |
) |
|
|
(13 |
)% |
Net income |
|
$ |
3,006 |
|
|
$ |
9,555 |
|
|
$ |
(6,549 |
) |
|
N/M |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Other information: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Gross profit percentage (3) |
|
|
15.3 |
% |
|
|
19.6 |
% |
|
|
(4.3 |
)% |
|
|
|
|
Adjusted gross profit percentage (3) |
|
|
30.7 |
% |
|
|
35.4 |
% |
|
|
(4.7 |
)% |
|
|
|
|
Property, plant and equipment expenditures |
|
$ |
18,480 |
|
|
$ |
14,760 |
|
|
$ |
3,720 |
|
|
|
|
_____________________________
N/M-Not meaningful.
23
The following tables provide key operating metrics for the fertilizer and major industrial products, the increase or decrease between those periods, and the percentage increase or decrease between those periods with respect to each line item:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Three Months Ended June 30, |
|
|
|
|
|
Percentage |
|
|||||||
Product (tons sold) |
|
2025 |
|
|
2024 |
|
|
Change |
|
|
Change |
|
||||
AN & Nitric Acid |
|
|
161,509 |
|
|
|
147,619 |
|
|
|
13,890 |
|
|
|
9 |
% |
Urea ammonium nitrate (UAN) |
|
|
151,807 |
|
|
|
137,499 |
|
|
|
14,308 |
|
|
|
10 |
% |
Ammonia |
|
|
66,069 |
|
|
|
72,294 |
|
|
|
(6,225 |
) |
|
|
(9 |
)% |
Total |
|
|
379,385 |
|
|
|
357,412 |
|
|
|
21,973 |
|
|
|
6 |
% |
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
Three Months Ended June 30, |
|
|
|
|
|
Percentage |
|
|||||||
Gross Average Selling Prices (price per ton) |
|
2025 |
|
|
2024 |
|
|
Change |
|
|
Change |
|
||||
AN & Nitric Acid |
|
$ |
382 |
|
|
$ |
396 |
|
|
$ |
(14 |
) |
|
|
(4 |
)% |
Urea ammonium nitrate (UAN) |
|
$ |
344 |
|
|
$ |
311 |
|
|
$ |
33 |
|
|
|
11 |
% |
Ammonia |
|
$ |
406 |
|
|
$ |
394 |
|
|
$ |
12 |
|
|
|
3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Three Months Ended June 30, |
|
|
|
|
|
Percentage |
|
|||||||
Average Benchmark Prices (price per ton) |
|
2025 |
|
|
2024 |
|
|
Change |
|
|
Change |
|
||||
Tampa Ammonia Benchmark |
|
$ |
416 |
|
|
$ |
440 |
|
|
$ |
(24 |
) |
|
|
(5 |
)% |
NOLA UAN |
|
$ |
344 |
|
|
$ |
246 |
|
|
$ |
98 |
|
|
|
40 |
% |
Net Sales
Net sales increased during the second quarter of 2025 compared to the prior year period driven by the impact of improved pricing for UAN and ammonia, as well as higher sales volumes for UAN and for our AN & Nitric Acid product group. Partially offsetting this increase were lower ammonia sales volumes and a lower average price within our AN & Nitric Acid product group.
Gross Profit
As noted in the table above, we recognized a gross profit of $23.2 million for the second quarter of 2025 compared to $27.4 million for the same period in 2024, or a $4.2 million decrease. Overall, our gross profit percentage was 15.3% compared to 19.6% for the same period in 2024. Our adjusted gross profit percentage decreased to 30.7% for the second quarter of 2025 from 35.4% for the second quarter of 2024. Our gross profit for the second quarter of 2025 was lower compared to the same period of 2024 primarily due to higher natural gas costs and higher depreciation due to recent investments in our facilities. These cost increases were partially offset by higher net sales and lower Turnaround expenses.
Selling, General and Administrative
Our SG&A expenses were $9.8 million for the second quarter of 2025, a decrease of $1.7 million compared to the same period in 2024. The net decrease was primarily driven by decreases in professional fees, insurance and other miscellaneous expenses items, partially offset by an increase in payroll related expenses.
Other expense, net
Other expense, net for the second quarter of 2025 consisted primarily of asset write-downs, which were lower in 2024 compared to 2025.
Interest Expense
Interest expense for the second quarter of 2025 was $7.9 million compared to $8.4 million for the same period in 2024. The decrease was primarily due to a lower outstanding balance on our Senior Secured Notes as a result of repurchases.
(Loss) Gain on Extinguishment of Debt
During the second quarter of 2025, we repurchased $32.4 million in principal amount of our Senior Secured Notes for approximately $32.1 million, which was accounted for as an extinguishment of debt. Including our write-off of the associated remaining portion of unamortized debt issuance costs, we recognized a loss on extinguishment of debt of approximately $0.1 million. During the second quarter of 2024, we repurchased $63.7 million in principal amount of our Senior Secured Notes for approximately $60.9 million. Including our write-off of the associated remaining portion of unamortized debt issuance costs, we recognized a gain on extinguishment of debt of approximately $1.9 million.
24
Non-operating Other Income, net
Non-operating other income, net for the second quarter of 2025 was $1.5 million compared to $2.9 million for the same period of 2024, primarily related to interest income earned during both periods from our short-term investments. Our average short-term investments balance including cash equivalents, was lower during the second quarter of 2025 compared to the second quarter of 2024.
Provision for Income Taxes
The provision for income taxes for the second quarter of 2025 was $1.1 million compared to $1.3 million for the same period of 2024. The resulting effective tax rate for the second quarter of 2025 was a provision on pre-tax income of 26.5% compared to 11.6% for the same period of 2024. For the second quarter of 2025, the effective tax rate was higher than the statutory rate primarily due to nondeductible compensation expense and state taxes. For the second quarter of 2024, the effective tax rate is lower than the statutory rate primarily due to nondeductible compensation and deferred benefits from state tax law changes. See discussion in Note 7.
Six Months Ended June 30, 2025 Compared to Six Months Ended June 30, 2024
The following table contains certain financial information for the six months ended June 30, 2025 and 2024, the increase or decrease between those periods, and the percentage increase or decrease between those periods with respect to each line item:
|
|
|
|
|
|
|
||
|
|
Six Months Ended June 30, |
|
|
|
Percentage |
||
|
|
2025 |
|
2024 |
|
Change |
|
Change |
|
|
(Dollars In Thousands) |
|
|
||||
Net sales: |
|
|
|
|
|
|
|
|
AN & Nitric Acid |
|
$119,325 |
|
$106,877 |
|
$12,448 |
|
12 % |
Urea ammonium nitrate (UAN) |
|
96,127 |
|
84,000 |
|
12,127 |
|
14 % |
Ammonia |
|
60,102 |
|
67,978 |
|
(7,876) |
|
(12)% |
Other |
|
19,174 |
|
19,422 |
|
(248) |
|
(1)% |
Total net sales |
|
$294,728 |
|
$278,277 |
|
$16,451 |
|
6 % |
|
|
|
|
|
|
|
|
|
Gross profit: |
|
|
|
|
|
|
|
|
Adjusted gross profit (1) |
|
$82,871 |
|
$89,895 |
|
$(7,024) |
|
(8)% |
Depreciation and amortization (2) |
|
(40,680) |
|
(35,848) |
|
(4,832) |
|
13 % |
Turnaround expense |
|
(4,634) |
|
(4,354) |
|
(280) |
|
6 % |
Total gross profit |
|
37,557 |
|
49,693 |
|
(12,136) |
|
(24)% |
Selling, general and administrative expense |
|
19,997 |
|
21,841 |
|
(1,844) |
|
(8)% |
Other expense, net |
|
2,599 |
|
2,189 |
|
410 |
|
19 % |
Operating income |
|
14,961 |
|
25,663 |
|
(10,702) |
|
(42)% |
Interest expense, net |
|
15,950 |
|
18,114 |
|
(2,164) |
|
(12)% |
Loss (gain) on extinguishment of debt |
|
59 |
|
(3,013) |
|
3,072 |
|
N/M |
Non-operating other income, net |
|
(3,215) |
|
(6,469) |
|
3,254 |
|
(50)% |
Provision for income taxes |
|
801 |
|
1,853 |
|
(1,052) |
|
(57)% |
Net income |
|
$1,366 |
|
$15,178 |
|
$(13,812) |
|
(91)% |
|
|
|
|
|
|
|
|
|
Other information: |
|
|
|
|
|
|
|
|
Gross profit percentage (3) |
|
12.7 % |
|
17.9 % |
|
(5.2)% |
|
|
Adjusted gross profit percentage (3) |
|
28.1 % |
|
32.3 % |
|
(4.2)% |
|
|
Property, plant and equipment expenditures |
|
$39,347 |
|
$33,047 |
|
$6,300 |
|
|
_____________________________
N/M-Not meaningful.
The following tables provide key operating metrics for the fertilizer and major industrial products, the increase or decrease between those periods, and the percentage increase or decrease between those periods with respect to each line item:
25
|
|
Six Months Ended June 30, |
|
|
|
Percentage |
||
Product (tons sold) |
|
2025 |
|
2024 |
|
Change |
|
Change |
AN & Nitric Acid |
|
312,040 |
|
276,420 |
|
35,620 |
|
13 % |
Urea ammonium nitrate (UAN) |
|
300,372 |
|
272,432 |
|
27,940 |
|
10 % |
Ammonia |
|
139,472 |
|
167,125 |
|
(27,653) |
|
(17)% |
Total |
|
751,884 |
|
715,977 |
|
35,907 |
|
5 % |
|
|
Six Months Ended June 30, |
|
|
|
Percentage |
||
Gross Average Selling Prices (price per ton) |
|
2025 |
|
2024 |
|
Change |
|
Change |
AN & Nitric Acid |
|
$382 |
|
$387 |
|
$(5) |
|
(1)% |
Urea ammonium nitrate (UAN) |
|
$320 |
|
$308 |
|
$12 |
|
4 % |
Ammonia |
|
$431 |
|
$407 |
|
$24 |
|
6 % |
|
|
Six Months Ended June 30, |
|
|
|
Percentage |
||
Average Benchmark Prices (price per ton) |
|
2025 |
|
2024 |
|
Change |
|
Change |
Tampa Ammonia Benchmark |
|
$455 |
|
$453 |
|
$2 |
|
0 % |
NOLA UAN |
|
$310 |
|
$249 |
|
$61 |
|
24 % |
Net Sales
Net sales of our primary products increased during the first half of 2025 compared to the prior year period driven by the impact of higher volumes for UAN and our AN & Nitric Acid product group and improved pricing for UAN and ammonia. Partially offsetting this increase was lower pricing for our AN & Nitric Acid product group and lower ammonia sales volumes. Additionally, we benefited from a healthy increase in downstream upgraded product production volumes.
Gross Profit
As noted in the table above, we recognized a gross profit of $37.6 million for the first half of 2025 compared to $49.7 million for the same period in 2024, a $12.1 million reduction. Overall, our gross profit percentage was 12.7% compared to a gross profit percentage of 17.9% for the same period in 2024. Our adjusted gross profit percentage was 28.1% for the first half of 2025 compared to 32.3% for the same period in 2024. Our gross profit for the first half of 2025 was lower compared to the same period of 2024 primarily due to higher natural gas costs and higher depreciation due to recent investments in our facilities. These cost increases were partially offset by higher net sales.
Selling, General and Administrative
Our SG&A expenses were $20.0 million for the first half of 2025, a decrease of $1.8 million compared to the same period in 2024. The net decrease was primarily driven by decreases in professional fees, insurance and other miscellaneous expenses items, partially offset by an increase in payroll related expenses.
Interest Expense
Interest expense for the first half of 2025 was $16.0 million compared to $18.1 million for the same period in 2024. The decrease primarily related to reduced interest expense as a result of repurchases of Senior Secured Notes made during 2024 and the second quarter of 2025.
(Loss) gain on Extinguishment of Debt
During the first half of 2025, we repurchased $32.4 million in principal amount of our Senior Secured Notes for approximately $32.1 million, which was accounted for as an extinguishment of debt. Including our write-off of the associated remaining portion of unamortized debt issuance costs, we recognized a loss on extinguishment of debt of approximately $0.1 million. During the first half of 2024, we repurchased $96.6 million of our Senior Secured Notes through open market transactions for approximately $92.2 million. As a result, we recognized a gain on extinguishment of debt, net of issuance costs, of approximately $3.0 million.
Other Expense, net
Other expense, net during the first half of 2025 and 2024 consisted primarily of asset write-downs related to assets no longer being used in operations. The asset write downs were lower in the first half of 2025 compared to the first half of 2024 while the write-downs in the first half of 2024 were partially offset by higher short-term rental income from railcar subleases.
26
Non-operating Other Income, net
Non-operating other income, net for the first half of 2025 was $3.2 million compared to $6.5 million for the same period of 2024, primarily related to interest income earned during both periods from our short-term investments.
Provision for Income Taxes
The provision for income taxes for the first half of 2025 was $0.8 million compared to $1.9 million for the same period of 2024. The resulting effective tax rate for the first half 2025 was 37.0% compared to 10.9% for the same period of 2024. For the first half of 2025, the effective tax rate is higher than the statutory rate primarily due to nondeductible compensation expense and state taxes. For the first half of 2024, the effective tax rate is lower than the statutory rate primarily due to nondeductible compensation and deferred benefits from state tax law changes. See discussion in Note 7.
LIQUIDITY AND CAPITAL RESOURCES
The following table summarizes our cash flow activities for the six months ended June 30:
|
|
2025 |
|
|
2024 |
|
|
Change |
|
|||
|
|
(In Thousands) |
|
|||||||||
Net cash flows from operating activities |
|
$ |
25,001 |
|
|
$ |
65,489 |
|
|
$ |
(40,488 |
) |
|
|
|
|
|
|
|
|
|
|
|||
Net cash flows from investing activities |
|
$ |
4,826 |
|
|
$ |
168,786 |
|
|
$ |
(163,960 |
) |
|
|
|
|
|
|
|
|
|
|
|||
Net cash flows from financing activities |
|
$ |
(44,443 |
) |
|
$ |
(118,973 |
) |
|
$ |
74,530 |
|
Net Cash Flow from Operating Activities
Net cash provided by operating activities was $25.0 million for the first six months of 2025 compared to $65.5 million for the same period of 2024, a change of $40.5 million. The decrease was primarily a result of higher cost of sales, changes in working capital and lower interest income on our short-term investments.
Net Cash Flow from Investing Activities
Net cash provided by investing activities was $4.8 million for the first six months of 2025 compared to $168.8 million for the same period of 2024, a change of $164.0 million.
For the first six months of 2025, the net cash provided by investing activities primarily related to proceeds from short-term investments of $154.6 million, partially offset by purchases of short-term investments of $110.3 million and expenditures for property, plant and equipment of $39.3 million.
For the first six months ended 2024, the net cash provided by investing activities primarily related to proceeds from short-term investments of $236.5 million, partially offset by purchases of short-term investments of $34.7 million and expenditures for property, plant and equipment of $33.0 million.
Net Cash Flow from Financing Activities
Net cash used by financing activities was $44.4 million for the first six months of 2025 compared to $119.0 million for the same period of 2024, a change of $74.5 million.
For the first six months of 2025, the net cash used by financing activities primarily consisted of repurchases of our Senior Secured Notes of $32.1 million, payments on our Secured Financing due 2025 and short-term financing of $11.3 million and $1.2 million for tax withholding obligations related to the vesting of equity awards.
For the first six months of 2024, the net cash used by financing activities primarily consisted of repurchases of our Senior Secured Notes of $92.2 million, payments on our Secured Financing due 2025 and short-term financing of $11.8 million, repurchases of $12.0 million of common stock and $2.2 million for tax withholding obligations related to the vesting of equity awards.
27
Capitalization
The following table summarizes our total cash and cash equivalents, short-term investments, long-term debt and stockholders’ equity as of June 30, 2025 and December 31, 2024:
|
|
June 30, 2025 |
|
|
December 31, 2024 |
|
||
|
|
(In Millions) |
|
|||||
Cash and cash equivalents |
|
$ |
5.6 |
|
|
$ |
20.2 |
|
Short-term investments |
|
|
119.3 |
|
|
|
164.0 |
|
Total cash, cash equivalents and short-term investments |
|
$ |
124.9 |
|
|
$ |
184.2 |
|
Long-term debt: |
|
|
|
|
|
|
||
Revolving Credit Facility |
|
$ |
— |
|
|
$ |
— |
|
Senior Secured Notes due 2028 (1) |
|
|
446.1 |
|
|
|
478.4 |
|
Secured Financing due 2025 |
|
|
5.5 |
|
|
|
8.5 |
|
Finance Leases |
|
|
5.5 |
|
|
|
3.9 |
|
Unamortized debt issuance costs (2) |
|
|
(4.5 |
) |
|
|
(5.6 |
) |
Total long-term debt, including current portion, net |
|
|
452.6 |
|
|
$ |
485.2 |
|
Total stockholders' equity |
|
|
495.8 |
|
|
$ |
491.6 |
|
_____________________________
We currently have a revolving credit facility pursuant to a credit agreement, dated December 21, 2023, between us and the lenders identified on the signature pages thereof and JPMorgan Chase Bank, N.A, as administrative agent (the “Revolving Credit Facility”), with a borrowing base up to an initial maximum of $75 million, with an option to increase the maximum by an additional $25 million (which amount is uncommitted). Availability under the Revolving Credit Facility is subject to a borrowing base and an availability block of $7.5 million which is applied against the $75 million initially reducing the maximum (which can be removed by us at our sole discretion, subject to the satisfaction of certain conditions). The Revolving Credit Facility provides for a sub-facility for the issuance of letters of credit in an aggregate amount not to exceed $10 million, with the outstanding amount of any such letters of credit reducing availability for borrowings. As of June 30, 2025, our Revolving Credit Facility was undrawn and had approximately $46 million of availability. See Note 4 for further discussion of the Revolving Credit Facility.
For the full year of 2025, we expect capital expenditures to be approximately $80 million to $90 million of which $60 million to $65 million is expected to be spent on sustaining production, with the remainder spent on growth initiatives.
From time to time, when the Company exceeds the funding threshold in our natural gas purchase commitments, the Company is required to fund cash collateral to our counterparty.
As of June 30, 2025, we had approximately $124.9 million of cash and short-term investments. From time to time, we may seek to deploy capital through common stock repurchases or the early redemption of outstanding debt. Such repurchases may be made in open market purchases, privately negotiated transactions or otherwise and will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved may be material.
We believe that the combination of our cash and cash equivalents, short-term investments, the availability under our Revolving Credit Facility and our cash flow from operations will be sufficient to fund our anticipated liquidity needs for the next twelve months including the full repayment of the Secured Financing due 2025 in August 2025.
Compliance with Long-Term Debt Covenants
As discussed in Note 4, the Revolving Credit Facility requires, among other things, that we meet a financial covenant. The Revolving Credit Facility does not include financial covenant requirements unless a defined covenant trigger event has occurred and is continuing. As of June 30, 2025, no trigger event had occurred.
Loan Agreements
Senior Secured Notes due 2028 – LSB had $446.1 million aggregate principal amount of Senior Secured Notes outstanding as of June 30, 2025. Interest is to be paid semiannually in arrears on May 15th and October 15th. The Senior Secured Notes mature on October 15, 2028.
Secured Financing due 2025 – We are a party to a $30 million secured financing arrangement with an affiliate of Eldridge (the “Secured Financing due 2025”). Principal and interest are payable in 60 equal monthly installments with a final balloon payment of approximately $5 million due in August 2025.
28
Revolving Credit Facility – At June 30, 2025, our Revolving Credit Facility was undrawn and had approximately $46 million of availability, based on our eligible collateral, less outstanding letters of credit as of that date. Also see discussion above under “Compliance with Long-Term Debt Covenants.”
Finance Leases – Our finance leases consist primarily of leases on railcars. Most of our railcar leases are classified as operating leases.
Capital Expenditures – First Six Months of 2025
For the first six months of 2025, capital expenditures relating to property, plant and equipment were $39.3 million. The capital expenditures were funded primarily from cash and working capital.
See discussion above under “Capitalization” for our total expected capital expenditures for the remainder of 2025.
Equity and Debt Repurchases
In May 2023, our Board of Directors authorized a $150 million stock repurchase program. The program is intended as a means to maximize stockholder value by returning capital to stockholders. Under the repurchase program, we are authorized to purchase shares from time to time through open market or privately negotiated transactions. Such purchases may be made pursuant to Rule 10b5-1 plans or other means as determined by our management and in accordance with the requirements of the Securities and Exchange Commission (the “SEC”). The repurchase program does not obligate us to purchase any particular number or type of securities. During the six months ended June 30, 2025, we did not repurchase any of our shares of common stock. The repurchase program may be suspended, terminated or modified at any time for any reason.
During the six months ended June 30, 2025, we repurchased $32.4 million in principal amount of our Senior Secured Notes for approximately $32.1 million, which was accounted for as an extinguishment of debt. The debt repurchase was intended as a means to deleverage our balance sheet and reduce future interest costs while maintaining a balanced capital allocation strategy that provides an appropriate level of liquidity to fund our operations and future growth opportunities.
Expenses Associated with Environmental Regulatory Compliance
We are subject to specific federal and state environmental compliance laws, regulations and guidelines. As a result, our expenses were $1.9 million for the first six months ended June 30, 2025 in connection with environmental projects. For the remainder of 2025, we expect to incur expenses ranging from $2.1 million to $2.3 million in connection with additional environmental projects. However, it is possible that the actual costs could be significantly different than our estimates.
Seasonality
We believe sales of fertilizer products to the agricultural industry are seasonal, while sales into the industrial sectors generally are less susceptible to seasonal fluctuations. The selling seasons for fertilizer products are primarily during the spring and fall planting seasons, which typically extend from March through June and from September through November in the geographical markets where we distribute the majority of our fertilizer products. As a result, we typically increase our inventory of fertilizer products prior to the beginning of each planting season in order to meet the demand for our products. In addition, the amount and timing of sales to the agricultural markets depend upon weather conditions and other circumstances beyond our control.
Performance and Payment Bonds
We are contingently liable to sureties in respect of insurance bonds issued by the sureties in connection with certain contracts entered into by subsidiaries in the normal course of business. These insurance bonds primarily represent guarantees of future performance of our subsidiaries. As of June 30, 2025, we have agreed to indemnify the sureties for payments, up to $10.3 million, made by them in respect of such bonds.
New Accounting Pronouncements
Refer to Note 1 for recently issued accounting standards.
Critical Accounting Policies and Estimates
See “Critical Accounting Policies and Estimates,” Item 7 of our Form 10-K for the year ended December 31, 2024, filed with the SEC on February 27, 2025 (the “2024 Form 10-K”). In addition, the preparation of financial statements requires us to make estimates and assumptions that affect the reported amount of assets, liabilities, revenues and expenses and disclosures of contingencies and fair values, including, but not limited to, various environmental and legal matters, including matters discussed under footnote A of Note 5.
Income Taxes - Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those differences are expected to be recovered or settled. We establish valuation allowances if we believe it is more-likely-than-not that some or all of deferred tax assets will not be realized. Significant judgment is applied in evaluating the need for and the magnitude of appropriate valuation allowances against deferred tax assets.
29
It is also reasonably possible that the estimates and assumptions utilized as of June 30, 2025, could change in the near term. Actual results could differ materially from these estimates and judgments, as additional information becomes known.
Non-GAAP Financial Measures
Management uses adjusted gross profit as a supplemental measure to review and assess the performance of our core business operations and for planning purposes. We define adjusted gross profit as gross profit excluding depreciation and amortization and Turnaround expenses included in our cost of sales, which we believe are not reflective of our operating performance in a given period.
Adjusted gross profit is a metric that provides investors with greater transparency to the information used by management in its financial and operational decision-making. We believe this metric is useful to investors because it facilitates comparisons of our core business operations across periods on a consistent basis. Management believes that the non-GAAP measure presented in this Form 10-Q, when viewed in combination with our results prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”), provides a more complete understanding of the factors and trends affecting our business and performance.
Adjusted gross profit is not a measure of financial performance under U.S. GAAP, and should not be considered a substitute for gross profit, which we consider to be the most directly comparable U.S. GAAP measure. Adjusted gross profit has limitations as an analytical tool, and when assessing our operating performance, investors should not consider adjusted gross profit in isolation, or as a substitute for gross profit prepared in accordance with U.S. GAAP. Adjusted gross profit may not be comparable to similarly titled measures of other companies and other companies may not calculate such measure in the same manner as we do.
The following table reconciles gross profit to adjusted gross profit.
|
|
Three Months Ended June 30, |
||
|
|
2025 |
|
2024 |
Reconciliation of Gross Profit to Adjusted Gross Profit: |
|
(In Thousands) |
||
Gross profit: |
|
23,173 |
|
27,415 |
Depreciation and amortization |
|
20,617 |
|
18,754 |
Turnaround expenses |
|
2,639 |
|
3,439 |
Adjusted gross profit |
|
46,429 |
|
49,608 |
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
Item 3. Quantitative and Qualitative Disclosures about Market Risk
General
Our results of operations and operating cash flows are impacted by changes in market prices of ammonia and natural gas and changes in market interest rates.
Forward Sales Commitments Risk
Periodically, we enter into forward firm sales commitments for products to be delivered in future periods. As a result, we could be exposed to embedded losses should our product costs exceed the firm sales prices at the end of a reporting period. At June 30, 2025, we had no embedded losses associated with sales commitments with firm sales prices.
Commodity Price Risk
A substantial portion of our products and raw materials are commodities whose prices fluctuate as market supply and demand fundamentals change. Since we are exposed to commodity price risk, we periodically enter into contracts to purchase natural gas for anticipated production needs to manage risk related to changes in prices of natural gas commodities. Generally, these contracts are considered normal purchases because they provide for the purchase of natural gas that will be delivered in quantities expected to be used over a reasonable period of time in the normal course of business, and as such, are exempt from derivative accounting requirements. At June 30, 2025, we had no outstanding natural gas contracts which are subject to derivative accounting requirements.
Interest Rate Risk
We may be exposed to variable interest rate risk with respect to our Revolving Credit Facility when there are outstanding borrowings. As of June 30, 2025, we had no outstanding borrowings on this credit facility and no other variable rate borrowings. We currently do not hedge our interest rate risk associated with our variable interest loan.
30
Item 4. Controls and Procedures
The Company maintains disclosure controls and procedures as defined in Rule 13a-15 under the Exchange Act designed to provide reasonable assurance that the information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. These include controls and procedures designed to ensure that this information is accumulated and communicated to the Company's management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Management, with the participation of the Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company's disclosure controls and procedures as of June 30, 2025. Based on this evaluation, the Company's Chief Executive Officer and Chief Financial Officer have concluded that the Company's disclosure controls and procedures were effective as of June 30, 2025, at the reasonable assurance level. There were no changes to our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended June 30, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
31
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Certain statements contained within this report may be deemed “Forward-Looking Statements” within the meaning of U.S. federal securities laws. All statements in this report other than statements of historical fact are Forward-Looking Statements that are subject to known and unknown risks, uncertainties and other factors, many of which are difficult to predict or outside of the Company’s control, which could cause actual results and performance of the Company to differ materially from those expressed in, or implied or projected by, such statements. Any such Forward-Looking Statements are not guarantees of future performance. The words “believe,” “expect,” “anticipate,” “intend,” “plan,” “may,” “could,” and similar expressions identify Forward-Looking Statements. All Forward-Looking Statements speak only as of the date on which they are made. Forward-Looking Statements contained herein include, but are not limited to:
While we believe, the expectations reflected in such Forward-Looking Statements are reasonable, we can give no assurance such expectations will prove to have been correct. There are a variety of factors which could cause future outcomes to differ materially from those described in this report, including, but not limited to, the following:
32
Given these uncertainties, all parties are cautioned not to place undue reliance on such Forward-Looking Statements. Except to the extent required by law, we disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the Forward-Looking Statements contained herein to reflect future events or developments.
33
PART II
OTHER INFORMATION
Item 1. Legal Proceedings
We are from time to time subject to various legal proceedings and claims arising in the ordinary course of business. For further discussion of our legal matters, see “Note 5. Commitments and Contingencies—Legal Matters” in the notes to the Condensed Consolidated Financial Statements in this report.
Item 1A. Risk Factors
Reference is made to Item 1A of our 2024 Form 10-K filed with the SEC on February 27, 2025. Except as set forth below, there were no material changes from the risk factors disclosed in our 2024 Form 10-K.
Our business and customers are sensitive to adverse economic cycles and a prolonged deterioration of global market and economic conditions could have a material adverse effect on our business, financial condition, results of operations and cash flow.
From time to time, our business is affected by cyclical factors such as inflation, currency exchange rates, global energy policy and costs, regulatory policies (including tariffs), global market conditions and economic downturns in specific industries. Certain sales are sensitive to the level of activity in the agricultural, mining, automotive and housing industries. Therefore, substantial changes in these macroeconomic factors could adversely affect our operating results, liquidity, financial condition and capital resources.
A slowdown of, or persistent weakness in, economic activity caused by a deterioration of global market and economic conditions could adversely affect our business in the following ways, among others: conditions in the credit markets could impact the ability of our customers and their customers to obtain sufficient credit to support their operations; the failure of our customers to fulfill their purchase obligations could result in increases in bad debts and affect our working capital; and the failure of certain key suppliers could increase our exposure to disruptions in supply or to financial losses. We also may experience declining demand and falling prices for some of our products due to our customers’ reluctance to replenish inventories. The overall impact of a global economic downturn or reduced overall global trade on us is difficult to predict, and our business could be materially adversely impacted.
In addition, conditions in the international market for nitrogen fertilizer significantly influence our operating results. The international market for fertilizers is influenced by such factors as the relative value of the U.S. currency and its impact on the importation of fertilizers, foreign agricultural policies, the existence of, or changes in, import or foreign currency exchange barriers in certain foreign markets and other regulatory policies (including tariffs) of foreign governments, as well as the U.S. laws and policies affecting foreign trade and investment.
For example, the U.S. government recently announced and, in some cases, implemented tariffs on certain products from various countries, which resulted in certain affected countries imposing or threatening to impose retaliatory or reciprocal tariffs on products from the U.S., including agricultural products such as corn. The trade policies and tariff initiatives of the current Presidential administration could adversely affect certain markets within which we operate. Specifically, the imposition of tariffs on agricultural products, including any retaliatory or reciprocal tariffs imposed by other countries, could impact the selling prices of our products or the cost of imported components or equipment used in our capital activities. In addition, such policies could lead to reduced demand for agricultural and consumer products, increase input costs for our customers, and disrupt supply chains.
The ultimate impact of changing trade policies on our business will depend on various factors, including the magnitude, duration and nature of tariffs. While we actively monitor these developments, we may not be able to fully mitigate the adverse impact of potential tariff initiatives or other trade-related disruptions.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On May 15, 2025, we issued an aggregate of 83,800 restricted stock units under the LSB Industries, Inc. 2025 Long-Term Incentive Plan to certain non-employee directors as compensation for their service on our board of directors for the 2025 fiscal year. The restricted stock units were issued pursuant to the exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended. Each restricted stock unit represents the right to receive one share of common stock.
Item 3. Defaults upon Senior Securities
Not applicable
Item 4. Mine Safety Disclosures
Not applicable
34
Item 5. Other Information
Adoption of 10b5-1 Trading Plans by Our Officers and Directors
On
Other than as described above, during the three months ended June 30, 2025, none of the Company’s directors or executive officers
35
Item 6. Exhibits
See “Index to Exhibits” on page 36.
Index to Exhibits Item 6.
Exhibit Number |
|
Exhibit Title |
|
Incorporated by Reference to the Following |
|
|
|
|
|
3(i).1 |
|
Restated Certificate of Incorporation of LSB Industries, Inc., dated January 21, 1977, as amended August 27, 1987 |
|
Exhibit 3(i).1 to the Company’s Form 10-K filed on February 28, 2013 |
|
|
|
|
|
3(i).2 |
|
Certificate of Amendment to the Restated Certificate of Incorporation of LSB Industries, dated September 23, 2021 |
|
Exhibit 3(i).2 to the Company’s Registration Statement on Form S-3 filed on November 16, 2021 |
|
|
|
|
|
3(ii).1 |
|
Second Amended and Restated Bylaws of LSB Industries, Inc., as amended by the December 17, 2024 amendment |
|
Exhibit 3(ii).1 to the Company’s Form 10-K filed February 27, 2025 |
|
|
|
|
|
10.1+ |
|
LSB Industries, Inc. 2025 Long Term Incentive Plan |
|
Exhibit 99.1 to the Company’s Registration Statement on Form S-8 filed on June 25, 2025 |
|
|
|
|
|
10.2(a)+ |
|
Form of Restricted Stock Unit Agreement (Directors) under the LSB Industries, Inc. 2025 Long Term Incentive Plan |
|
|
|
|
|
|
|
10.3(a)+ |
|
Form of Restricted Stock Unit Agreement (Executives Officers) under the LSB Industries, Inc. 2025 Long Term Incentive Plan |
|
|
|
|
|
|
|
10.4(a)+ |
|
Form of Restricted Stock Unit Agreement (Employees) under the LSB Industries, Inc. 2025 Long Term Incentive Plan |
|
|
|
|
|
|
|
31.1(a) |
|
Certification of Mark T. Behrman, Chief Executive Officer, pursuant to Sarbanes-Oxley Act of 2002, Section 302 |
|
|
|
|
|
|
|
31.2(a) |
|
Certification of Cheryl A. Maguire, Chief Financial Officer, pursuant to Sarbanes-Oxley Act of 2002, Section 302 |
|
|
|
|
|
|
|
32.1(a)(b) |
|
Certification of Mark T. Behrman, Chief Executive Officer, furnished pursuant to Sarbanes-Oxley Act of 2002, Section 906 |
|
|
|
|
|
|
|
32.2(a)(b) |
|
Certification of Cheryl A. Maguire, Chief Financial Officer, furnished pursuant to Sarbanes-Oxley Act of 2002, Section 906 |
|
|
|
|
|
|
|
101.INS(a) |
|
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
|
|
|
|
|
|
|
101.SCH(a) |
|
Inline XBRL Taxonomy Extension Schema Document |
|
|
|
|
|
|
|
101.CAL(a) |
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document |
|
|
|
|
|
|
|
101.DEF(a) |
|
Inline XBRL Taxonomy Extension Definition Linkbase Document |
|
|
|
|
|
|
|
101.LAB(a) |
|
Inline XBRL Taxonomy Extension Labels Linkbase Document |
|
|
|
|
|
|
|
101.PRE(a) |
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document |
|
|
|
|
|
|
|
104(a) |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
|
|
+ Management contract or compensatory plan or arrangement.
36
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has caused the undersigned, duly authorized, to sign this report on its behalf on this 30th day of July 2025.
LSB INDUSTRIES, INC. |
|
/s/ Cheryl A. Maguire |
Cheryl A. Maguire |
Executive Vice President and Chief Financial Officer |
(Principal Financial and Accounting Officer) |
37